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Abstract 
The dioxygenase DpgC performs a key step in the biosynthesis of 3,5-
dihydroxyphenylglycine (DPG), a nonproteogenic amino acid found in the vancomycin 
family of antibiotics. Remarkably, DpgC performs a 4-electron oxidation without the use 
of metals or cofactors. The tools of synthetic organic chemistry, enzymology and 
structural biology were used to study this enzyme. We have solved the first structure of 
an enzyme of this oxygenase class, in complex with a bound substrate mimic. The 
structure confirms the absence of cofactors, and electron density consistent with 
molecular oxygen is located adjacent to the site of oxidation on the substrate. The use of 
a designed, synthetic substrate analog allowed us to gain unique insights into the 
chemistry of oxygen activation. We systematically probed the importance of active site 
residues by engineering conservative changes using site-directed mutagenesis. The 
kinetic parameters of these constructs imply that the phenolic hydroxyls of the substrate 
are of particular importance. These conclusions were verified by kinetic evaluation of 
synthetic substrate analogs. We have synthesized cyclopropyl substrate derivatives to 
probe the electron transfer step. The single electron oxidation should produce a radical 
species capable of opening the cycloproyl ring, thus providing a handle of detection. Our 
results resolve the unique and complex chemistry of DpgC, a key enzyme in the 
biosynthetic pathway of an important class of antibiotics. 
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 1 
Introduction 
 Oxygen (O2) plays critical roles in respiration and metabolism in all aerobic 
organisms. All of the bio-accessible molecular oxygen in the atmosphere is in the triplet 
state, preventing its reactivity with organic compounds, which are typically in the singlet 
state. Nature has found several ways to deal with this spin-forbidden process. Enzymes 
that perform redox chemistry with dioxygen typically employ metals, such as iron1 or 
copper2, or easily oxidizable organic cofactors capable of transferring electrons to O2
1. 
While the vast majority of oxidoreductases operate in this fashion, a small number of 
enzymes have emerged that can catalyze oxidations or oxygenations without the use of 
metals or organic cofactors3.  
 The fact that these enzymes can harness the oxidizing power of O2 without 
cofactors is remarkable. Knowledge of how these enzymes catalyze this fascinating 
chemistry has begun to unfold. When mechanisms for the cofactor-independent 
enzymes are proposed, flavin-catalyzed chemistry4 is often cited as precedence.  
Numerous similarities exist between the two, and some general rules for activating 
oxygen can be learned from flavoenzymes5,6. The functionality of flavin cofactors stems 
from their ability to serve as a good electron sink, capable of accepting and donating 
electrons. The oxidized and reduced forms of flavin are shown in Figure 1-1. The 
electron-rich, reduced form of the flavin cofactor is capable of reducing molecular 
oxygen4. In a two-step mechanism, one-
electron transfer from reduced flavin to 
triplet oxygen forms a caged radical pair 
between superoxide and the flavin 
radical. After O2 spin inversion, radical 
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Figure 1-1. The oxidized and 
reduced forms of flavin cofactors. 
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rebound results in formation of flavin hydroperoxide, typically at the C4 position 7,8 
(Figure 1-2). Such a peroxyflavin is unstable and typically decays to form hydrogen 
peroxide and oxidized flavin, as seen in the flavin oxidases. Flavin-dependent 
monooxygenases are a second enzyme class able to stabilize this peroxy species so 
that a single atom of molecular oxygen is incorporated into a reacting partner, while the 
other oxygen atom becomes water9. Flavin-dependent monooxygenases can catalyze a 
variety of oxygenations including hydroxylations, epoxidations, and Baeyer–Villiger 
oxidations1,9. The specific type of oxygenation depends on the shape and chemical 
nature of the active site of each monooxygenase. An example of p-hydroxybenzoate 
hydrolase is shown in Figure 1-2.10. 
 
Figure 1-2. Single electron transfer from oxidized flavin leads to formation of a C4-
hydroperoxyflavin that can then expel H2O2 to reform oxidized flavin (Floc, top) or be used 
in monooxygenation reactions before reforming Flox (bottom).  The hydroxylation of para-
hydroxybenzoate is shown. 
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 Whereas there are hundreds of characterized flavin-dependent 
oxidase/oxygenases, a small subset of enzymes exist that can perform similar chemistry 
without the use of a flavin cofactor, or any cofactors for that matter.  Examples of these 
will be discussed in this chapter. 
 
Metal and cofactor-free oxidases 
 Urate oxidase (UOX) is a well-characterized enzyme in the purine degradation 
pathway. It catalyzes the oxidation of urate to 5-hydroxyisourate with concomitant 
conversion of molecular oxygen to hydrogen peroxide (Figure 1-3)11. At first glance, this 
reaction is similar to the O2-mediated oxidation of reduced flavin. In fact, there are 
structural similarities between urate and reduced flavin. Urate contains a core ene-
diamine functionality similar to that of the isoallaxazine structure in flavin, which allows 
rationalization of some of UOX’s activity. These similarities to flavin-dependent chemistry 
makes the lack of cofactor for this reaction reasonable12. A mechanism for the urate 
oxidase reaction has been proposed (Figure 1-3) in which urate reacts directly with O2 in 
a manner analogous to reduced flavin to form a urate hydroperoxide intermediate. Next, 
expulsion of H2O2 and 
hydration of the resulting 
dehydrourate generates 
the observed product, 5-
hydroxyisourate11. 
Several studies have 
identified reaction 
intermediates using 
Figure 1-3. Proposed mechanism for the conversion of urate 
to 5-hydroxyisourate catalyzed by urate oxidase. 
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 4 
techniques such as stopped-flow spectroscopy13 and rapid-mixing chemical quench 
studies14. The first intermediate in the pathway was assigned to be the urate dianion, 
which was confirmed by site-directed mutagenesis to be dependent on a Thr57-Lys10 
catalytic diad14. The second catalytically relevant intermediate was assigned to the urate 
hydroperoxide formed from the urate dianion and O2
13. 
 The X-ray crystal structure of UOX was determined in 199715 and this work was 
followed by several structural studies probing the active site with various inhibitors and 
dioxygen binding mimics16,17,18 (Figure 1-4). Cyanide had previously been shown to 
inhibit UOX19 and so was used in co-crystallization conditions with urate and UOX.  The 
cyanide was bound where the relevant water involved in hydroxylation is typically 
located. This is also proposed to be the site where molecular oxygen is bound18, despite 
the fact that a distinct hydrophobic pocket in the vicinity had been proposed to be the 
site of O2 binding based on observation of bound xenon
20. 
Figure 1-4. The active site of urate oxidase (PDB 
#3BJP) with urate and cyanide bound. Residues 
important for binding and catalysis are shown. The 
green lines represent important interactions. 
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 Urate oxidase is a classic example of an enzyme that can perform powerful 
chemistry without the aid of a metal or cofactor. Another example comes from the 
biosynthetic pathway to the cofactor pyrroloquinoline quinone (PQQ), which is a cofactor 
for bacterial alcohol dehydrogenases21. The substrate for this enzyme (PqqC), unlike the 
UOX system, does not structurally resemble flavin. The PQQ biosynthetic pathway in 
Klebsiella pneumoniae includes six genes, pqqA-F, which construct PQQ from glutamate 
and tyrosine (Figure 1-5). The 
function of all six gene products 
has not been determined, 
although some information has 
begun to emerge through 
structural and biochemical 
studies22.  PqqA, a small ~30 amino acid protein, is the source of the glutamate and 
tyrosine residues incorporated into PQQ. PqqE is proposed to make one of the first 
covalent linkages between these two amino acids, which are then cut from PqqA by the 
enzyme PqqF. The final catalyst in PQQ production, PqqC, is the most extensively 
studied enzyme in the biosynthetic pathway. It catalyzes an impressive ring cyclization 
and eight-electron oxidation of 3a-
(2-amino-2-carboxyethyl)-4,5-dioxo-
4,5,6,7,8,9-hexahydroquinoline-7,9-
dicarboxylic acid (AHQQ) to PQQ 
without the assistance of any 
metals or cofactors (Figure 1-6)23. 
  
Figure 1-5. The nitrogen and carbon atoms of PQQ 
(shown in bold) are from glutamate and tyrosine 
residues, which are extracted from the small protein 
PaaA. 
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Figure 1-6. The overall PqqC reaction (upper) 
involves cyclization and eight-electron oxidation of 
AHQQ to produce a pyrroloquinoline quinone (PQQ). 
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 In a collaborative effort, the Klinman and Schwarzenbacher laboratories have 
been deciphering the details of this enzyme-catalyzed reaction. The transformation of 
AHQQ to PQQ by PqqC was assayed via HPLC and an indirect reporter assay24. Only 
one enzyme turnover was detected and a rate constant of 0.38 ± 0.03 min-1 was 
determined. The single turnover event was shown to occur because of very tight binding 
of the product of the reaction. The enzyme consumed 3 mol of molecular oxygen per 
molecule of PQQ with a rate of O2 uptake (kobs= 0.38 min
-1) similar to the rate of PQQ 
formation.  The production of H2O2 was determined by two different methods, which 
gave the same rate constants (0.40 min-1) but different amounts of H2O2 formation. The 
methods measured H2O2 indirectly via a coupled horseradish peroxidase (HRP) assay. 
The first method involved in situ H2O2 formation (1 eq. measured), while the second 
involved denaturation of the PqqC before measuring H2O2 (2 eq. measured). The 
authors suggest that this variation is due to tightly bound H2O2 in the enzyme.  
 Structures were solved of apo-
PqqC (2.1 Å) and a PqqC/PQQ complex 
(2.3 Å)24. PqqC forms a seven-helix bundle 
which envelops the deeply buried, 
positively charged active site cavity 
(Figure 1-7).  This structure confirms the 
absence of any cofactors or metals. 
Orphan electron density is seen in 
proximity to the substrate that the authors 
suggest may be H2O2, but no evidence is 
presented to validate this claim.  
Figure 1-7. Structure of PqqC with 
PQQ bound (sticks). 
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Several residues were postulated to be of 
catalytic relevance, including three histidines 
(His84, His24, His154) proposed to function as 
enzymatic bases (Figure 1-8). A mechanism 
was proposed that involves initial cyclization by a 
1,4-addition of the primary amine to the 
conjugated ring structure. Next, the enzyme 
must function as a dehydrogenase/desaturase to 
remove eight electrons and eight protons from 
the substrate. Deprotonation and tautomerization 
gives a quinol intermediate, which is capable of direct transfer of electrons to O2. This 
substrate tautomerization/oxidation step is repeated three times to yield the product 
PQQ (Figure 1-9). 
 
Figure 1-8. Active site of PqqC with 
PQQ bound. The catalytic histidines 
are shown with important interactions 
indicated with dashed lines (orange). 
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Figure 1-9. The proposed reaction mechanism of PqqC. A) Ring cyclization of AHQQ to 
form the quinol, which will transfer electrons to O2, forming the oxidized quinone. B) An 
example of one of the 3 enzyme-catalyzed tautomerization/oxidation steps that must occur 
to form the final product, PQQ.
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 Based on the structural information, two active site variants were made and 
evaluated (His84Asn, His84Ala). Spectroscopic assays with these mutants in aerobic 
and anaerobic conditions allowed the assignment of two intermediates in the reaction25. 
A quinoid intermediate was proposed that, with His84 donating a proton to the C4 
oxygen, would tautomerize to the quinol (Figure 1-9). Both the quinoid and quinol 
species were observed thus validating the initial steps for the proposed mechanism. 
Unlike urate in the UOX system, the PqqC substrate, AHQQ, does not have structural 
similarities to reduced flavin. However, PQQ itself is a cofactor used in oxidation 
chemistry. So while this enzyme technically does not require an auxiliary cofactor, 
inherent redox activity is built into the product, potentially facilitating this fascinating 
chemistry.  
 The two oxidases discussed, UOX and PqqC, require the use of O2, but only as 
an oxidizing agent. As discussed in the introduction, flavo-enzymes can perform similar 
oxidation chemistry. However, they can also function as monooxygenases, incorporating 
an atom of oxygen from O2 into an organic substrate. Like oxidases, there are also 
limited examples of cofactor free monooxygenases. 
 
Quinone-forming, cofactor free monooxygenases 
 Natural products produced by bacteria of the Streptomyces genus have long 
been a source of study for research and medical purposes26.  Many antibiotics used 
today, including kanamycin, tetracycline, and streptomycin, were among the first isolated 
from Streptomyces27. The study of the biosynthetic pathways of these secondary 
metabolites has led to the discovery of interesting enzyme-catalyzed oxidation 
chemistry. In particular, a small class of quinone-forming, cofactor and metal free 
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oxygenases have be identified in type II polyketide synthase (PKS II) systems. These 
include TcmH from S. glaucescens28, ActVA-Orf6 from S. coelicolor29, AknX from S. 
galilaeus30, ElmH from S. olivaceus31, as well as several other homologus but non-
characterized enzymes3. These enzymes share significant sequence homology (40-
50%), and all catalyze very similar reactions (Figure 1-10). Examination of conserved 
residues of these enzymes via site-directed-mutagenesis led to some debate in the 
literature as to what amino acids were catalytically relevant. Initially in the TcmH system, 
cysteine residues were thought to 
impart functionality28. This was later 
questioned by data from the ActVA-
Orf6 enzyme, which suggested that a 
histidine was imperative for catalysis29. 
Again, this conclusion was disputed 
with data from AknX which indicated 
that the conserved histidine was in fact 
not necessary and a tryptophan 
residue was one of the essential 
catalytic residues30. A crystal structure 
would address these differences, and in 2003, the crystal structure of ActVA-Orf6 was 
published32. As structures from other enzymes in this family have yet to be published, 
the rest of the discussion of quinone-forming monooxygenases will be focused on 
ActVa-Orf6 from actinorhodin biosynthesis. 
 Actinorhodin, famous for its blue color, is a well known polyketide synthase 
(PKS) antibiotic from S. coelicolor (Figure 1-11). Even before the full genome of S. 
Figure 1-10. Some of the reactions catalyzed by 
quinone-forming, cofactor free monooxygenases. 
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coelicolor was completed33, the biosynthesis 
of actinorhodin was being studied34. ActVA-
Orf6 is a monooxygenase in this pathway that 
functions without the need for metals or 
cofactors.  Once the substrate for ActVA-Orf6 
was determined to be 6-deoxydihydrokalafungin (6-DDHK, Figure 1-12), biochemical 
studies were undertaken to understand how this enzyme functions29.  As alluded to 
earlier, His52 was targeted as a catalytic residue as it was the only residue that was 
conserved between ActVA-Orf6 and TcmH.  A His52Gln mutant had onlyl 5% activity of 
the wild-type enzyme, thus 
confirming the importance of 
this residue. This enzyme 
was also shown to have 
relaxed substrate specificity 
as it also accepted TcmH’s substrate (TcmF1, Figure 1-10). 
 Still, very little was understood about this enzyme’s catalytic reaction until a 
structure of ActVA-Orf6 was solved in 2003 with substrate and product analogs bound to 
the enzyme32.  The overall structure is a dimer with a ferredoxin-like structure composed 
of two  folds (Figure 1-13A). Examination of the active site, with a bound substrate 
analog, revealed potential catalytic residues. The His52 residue proposed to be of 
mechanistic importance was not located at the active site, but was found instead in the 
dimer interface. The reduced activity seen in previous biochemical assays with the 
His52Gln mutant was in reality due to disruption of this dimer interface. Based on the 
crystal structure, Tyr51, Asn62, Trp66, Arg 86, and Tyr72 were proposed to be 
O
O
-O2C
O
O
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O
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-
Actinorhodin
Figure 1-11. The antibiotic acntinorhodin 
produced by S. coelicolor. 
Figure 1-12. The oxygenation of 6-deoxydihydrokalafungin 
(6-DDHK) to dihydrokalafungin (DHK) by ActVA-Orf6. 
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catalytically relevant (Figure 1-13B,C). The carboxylate moiety of the substrate is 
exposed to the solvent, which explains the relaxed substrate tolerance. Sciara et al. 
proposed that 6-DDHK would bind to the enzyme and an anion (carbanion at C6) would 
be formed via deprotonation of Tyr72. This tyrosine appears to be activated as a base by 
hydrogen bonding to Arg86. Trp66 is a recognition element, donating a hydrogen bond 
to the oxygen of the C-11 carbonyl of the substrate and thus, contributing to the build up 
of negative charge. At this point, the carbanion at C-6 may be involved in directly 
reducing molecular oxygen to superoxide with subsequent formation of the C-6 peroxide 
(Figure 1-14). This is analogous to chemistry performed by flavoenzymes4.  Tyr51 and 
Asn62 are thought to help stabilize and direct this peroxo-intermediate through hydrogen 
Figure 1-13. The crystal structure of ActVA-Orf6 with a bound product 
analog (oxidized acetyl dithranol). A) The homodimer of ActVA-Orf6. 
The C-term domain is a -strand contributing to the other monomer’s -
sheet as well as forming the back of the active site. B) A close up of the 
ActVA-Orf6 active site with a bound product analog. C) Molecular 
depection of active site with important interactions shown.  
OH O OH
NHTrp66 OH
Tyr72
HN
NH2
N
H
Arg86
O
NH2
Asn62
OH
Tyr51
oxidized acetyl dithranolO
CO2
-
 12 
bonding. Protonation followed by dehydration 
would complete the catalytic cycle. Further 
studies with variants of these active site 
residues will need to be performed in order to 
confirm this mechanism. 
  While a mechanism was proposed, it 
was based on structures of substrate and 
product analogs bound to the enzyme that may 
not accurately reflect the active site geometry 
of the natural substrate. In addition, no 
information was obtained for oxygen binding. 
Molecular oxygen has been proposed to bind to proteins in hydrophobic cavities. Such a 
cavity exists in ActVA-Orf6 located near the C-6 site of oxidation, on the opposite side of 
the substrate from Tyr51 and Asn62. Perhaps this is an oxygen-binding cavity, however, 
no density was seen in this cavity nor have any experiments been performed to test this 
possibility. 
 So far, cofactor-free oxidases and monooxygenases have been discussed. 
Cofactor indepednent dioxygenases are also rare and studies of these enymes will be 
discussed in the next section. 
 
Ring-cleaving dioxygenases 
 Numerous examples exist of enzymes involved in bacterial degradation of 
aromatic compounds. Ring cleaving dioxygenases catalyze the addition of O2 to 
adjacent carbon atoms with a successive C-C bond cleavage35,36. These enzymes 
Figure 1-14. Proposed catalytic 
mechanism of ActVA-Orf6. 
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contain mono-nuclear iron centers that are essential for catalysis. In contrast are 
dioxygenolytic enzymes which insert dioxygen on non-adjacent carbons (i.e. C-2 and C-
4) such as quercetin 2,3 dioxygenase37, and the related 1H-3-hydroxy-4-oxo-quinoline 
2,4-dioxygenase (Qdo) and 1H-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase (Hod).  
These enzymes catalyze dioxygenation leading to the cleavage of two carbon bonds and 
concomitant release of carbon monoxide. 
While quercetin dioxygenase requires copper 
for catalysis, Qdo and Hod are notable in that 
they do not require a metal or cofactor for 
dioxygen or substrate activation (Figure 1-15). 
 Based on sequence analysis and secondary structure prediction, Qdo and Hod 
belong to the / hydrolase superfamily38. It is interesting to note that oxygenases are 
not typically part of this superfamily. Conserved structural motifs of the / hydrolases 
are a ‘nucleophilic elbow’ and a catalytic triad39.  In general, this triad consists of a 
nucleophile (Ser, Asp, or Cys), an acidic residue (Asp or Glu) and a histidine residue.  
The sequences of Qdo and Hod reveal that the nucleophile elbow (Sm-X-Ser-X-Sm-Sm; 
where Sm is a small amino acid, X is any amino acid) and the conserved histidine are 
present in these enzymes. However, the conserved acidic residue (Asp or Glu) could not 
be confirmed. Determination of catalytic residues would be facilitated if a crystal 
structure of these enzymes were solved.  Furthermore, structures could also validate the 
assignment of these oxygenases in the / hydrolase superfamily. Structural data may 
be forthcoming as the crystallization of both these proteins was reported in 200740,41. 
 A lack of structural data did not prevent acquisition of information about how 
these enzymes function. Dioxygenase activity was validated with 18O labeling studies, 
Figure 1-15. Reaction catalyzed by 
Qdo (R=H) and Hod (R=CH3). 
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indicating that both atoms of molecular oxygen were incorporated into the final product42. 
The significance of the conserved histidine residue (His244 of Qdo, His251 of Hod) was 
probed by point mutation to alanine. Biochemical characterization indicated that this 
variant had no activity38, thus confirming the importance of this conserved residue. 
UV/Vis spectroscopy was used to confirm the role of His251 in catalysis. Under anoxic 
conditions, the substrate is deprotonated in the wild-type Hod but not in His251Ala-Hod. 
This indicated that histidine was functioning as a general base43. The predicted 
nucleophilic serine residue was also examined. A serine to alanine mutation (Ser95 of 
Qdo) dramatically reduced catalytic efficiency to about 1% of the wild type (110 s-1μM-1 
to 1.73 s-1μM-1). However, this protein still showed come catalytic activity, indicating that 
while the serine plays an important role, it isn’t absolutely essential for catalysis. Other 
serine residues were mutated, but none had lower activity than the S95A-Qdo enzyme44.  
Also, the catalytically relevant acidic residue could not be determined. 
 Detailed kinetic studies were performed with Hod using both its natural substrate 
as well as the substrate for Qdo. It was found that dioxygenolysis proceeds via a 
compulsory-order ternary complex mechanism, in which the organic substrate binds 
prior to oxygen and evacuation of CO from the active site would occur before the 
product43.  At this point, the order of the mechanism and a catalytically important residue 
had been identified. How dioxygen was activated to react with the substrate was not 
understood.  In analogy to flavin-dependent enzymes, the substrate itself was thought to 
act as the reductant, transferring a single electron to dioxygen. A similar example was 
described for urate oxidase, where generation of a dianion was a critical step, occurring 
before reaction with dioxygen14.  Also, in glucose oxidase, it had been shown that a 
protonated histidine provided an ideal environment for electron transfer to O2
6. In order 
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to validate this hypothesis, EPR studies were conducted in model chemical reactions as 
well as the enzymatic system. In the model reactions, the substrates for Hod and Qdo  
underwent base-catalyzed dioxygenolysis in solution, which was characterized by EPR 
to indicate that a stabilized radical was indeed formed. Attempts to trap a superoxide 
species were hampered by complex mixtures and no conclusive results were obtained. 
However, when using the enzyme system in anoxic and oxic conditions, with and without 
a spin trap, no radical signals were detected. It is entirely possible that a spin-coupled, 
EPR silent radical pair or a short-lived free radical is formed that would not be detected 
by these methods.  It was nevertheless suggested that single electron transfer to 
dioxygen might still occur. A proposed mechanism is outlined in Figure 1-16. Once the 
substrate binds, deprotonation forms an anionic species that can easily undergo a one-
electron oxidation to reduce oxygen to superoxide. Radical recombination produces a 
peroxo-intermediate that could form the 2,4-endoperoxy species via an intramolecular 
attack on the carbonyl. Collapse with concomitant release of CO leads to the final 
product. 
 
Figure 1-16. Proposed catalytic mechanism for 2,4-dioxygenolysis by Hod. 
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 Another cofactor free dioxygenase has been isolated from the vancomycin 
biosynthetic pathway. Specifically, DpgC is a crucial enzyme in the biosynthesis of one 
of the non-natural amino acids (3,5-dihydroxyphenyl glycine) incorporated into 
vancomycin. Structural and biochemical characterization of this interesting enzyme is the 
topic of this thesis and thus will be discussed in more detail in the following chapters. 
 While the discussion so far has focused on naturally-occuring enzymes, 
scientists strive to understand these enzymes in-depth so that the knowledge gained 
may be applied to engineering new ones. The goal may be relaxed substrate specificity 
for industrial biocatalysts45, or perhaps for use in biosynthetic pathways that produce 
natural product analogs46. Sometimes, rational changes to enzyme residues can 
serendipitously lead to unexpected, yet stunning results. 
 
Engineering a cofactor-free oxygenase 
 Dihydroneopterin aldolase (DHNA) is an enzyme involved in the folate 
biosynthetic pathway that catalyzes the conversion of 7,8-dihydroneopterin (DNP) to 6-
hydroxymethyl-7,8-dihydropterin (DXP, Figure 1-17).  The hallmark of the DHNA-
catalyzed aldolase reaction is a general acid/base mechanism. A structure of DHNA 
from Staphylococcus aureus was solved in 199847 which allowed identification of active 
site residues. A conserved tyrosine (Tyr54) was implicated in the mechanism by 
activating the general base (lysine 100) via hydrogen bonding. To probe the role of this 
residue, Wang et al. made a Tyr54Phe construct of both the S. aureus DHNA and the 
homologous E. coli enzyme (Tyr53Phe EcDHNA)48. Interestingly, this mutation 
converted the aldolase to an oxygenase.  Extensive characterization by HPLC, NMR, 
MS, stopped-flow flourimetry, and various biochemical studies established that the same 
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initial enol intermediate was formed but the mechanism diverged to yield a different 
product (Figure 1-18). Instead, the anionic species undergoes a single electron transfer 
to O2, forming a superoxide that can undergo radical recombination with the substrate to 
produce a peroxo- intermediate. The authors propose dioxetanone formation followed by 
decomposition to form the product and formic acid. This mechanism was validated by 
detection of formic acid production as well as oxygen consumption. Also, isotopic 
labeling using H2O
18 confirmed the oxygen introduced into DXP was from O2 and not 
H2O. 
 
  
Figure 1-17. Reactions catalyzed by DHNA(top) and Y54F DHNA (bottom). 
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Figure 1-18. Proposed mechanism for formation of 7,8-dihydroxanthopterin (DXP) 
by the enzyme Y54F DHNA. 
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 This work illustrated that Tyr54’s major role was not in activation of a lysine for 
initial deprotonation, but in protonation of the enol intermediate. The formation of DXP 
was shown by kinetic data to be a result of enzyme catalysis, as opposed to oxidation of 
an enzyme-leaked enol intermediate. The mechanism proposed cited precedent for 
other metal and cofactor free oxygenases3.  This divergent enzyme activity was not 
anticipated, and it reaffirms that enzymes of very similar folds can catalyze very different 
reactions. Interestingly, an overlay of the structure of DHNA with UOX shows the 
remarkable structural similarities between these two enzymes (Figure 1-19). The 
substrates of the two 
enzymes even bind in the 
same pocket. One of the 
main differences is in the 
loops that make up the active 
site. While rational 
engineering is touted as a 
prospective tool, nature 
works in ways scientists still 
have yet to understand. 
Much work is still needed in 
the areas of protein structure 
and dynamics to truly 
appreciate how these 
systems work. 
 
Figure 1-19. An overlay is shown of the structures of 
UOX with urate bound (PDB # 1R51, blue) and DHNA 
with 6-hydroxymethyl-7,8-dihydropterin bound (PDB# 
2DHN,  green).  
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Conclusion 
 A reoccurring theme in cofactor and metal free oxidation enzymes is the ability of 
the organic substrate to be easily oxidized. The examples shown so far have all included 
at least one aromatic ring.  It is also interesting to note that while some of the examples 
did not require extraneous cofactors, several of the substrates themselves were 
biosynthetic precursors to cofactors that go on to perform very similar chemistry in other 
enzymes (PccQ, aldolase). A general picture is emerging that enzymes harness this 
inherent activity by providing a safe place to form reactive species while simultaneously 
facilitating the chemistry. Typically, an anion of the organic substrate is formed which will 
react more quickly. What is not well understood is the way these enzymes bind and 
control molecular oxygen. Enzymes dependent on flavins or metals have provided a 
framework for how this may happen. For example, the structure of BluB, a flavoenzyme 
from vitamin B12 biosynthesis, was recently solved
49 in which electron density in the 
active site, attributed to O2, is poised directly above the reduced flavin. Definitive 
evidence for the binding and control of molecular oxygen in the cofactor independent 
enzymes is still lacking, however.   
 Several techniques have emerged to probe oxygen binding. Examples include 
using xenon and oxygen gases under high-pressure conditions18. Also, oxygen 
surrogates such as cyanide17, nitrous oxide16, and even chloride ions50 have been used. 
In the literature there has been some debate as to the hydrophobic nature of the oxygen 
binding pocket18,50,51.  Recently, work was published in which the pathways of oxygen 
diffusion into flavoenzyme active sites were determined by computational methods52.  
The predicted pathways were verified using site-directed mutagenesis, kinetic analysis, 
and x-ray crystallographic analysis. The authors found that multiple pathways exist that 
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direct O2 to the reactive C4 atom of the flavin cofactor and that a specific set of 
hydrophobic residues formed the entry site for oxygen access. Capturing and assigning 
oxygen in crystal structures is a non-trivial task. For proteins participating in redox 
chemistry with O2, their task is to not only guiding the relatively hydrophobic oxygen to 
the active site, but also accommodating/stabilizing polar, reactive intermediates such as 
superoxide and peroxy-species. This explains the anomalies exposed when oxygen-
binding mimics have been used.  
 In order to gain a better understanding of how these cofactor free oxygenases 
work, and to perhaps gain some insight into oxygen binding, we undertook the study of 
DpgC.  The information we have gained from this enzyme will be laid out in detail in the 
following chapters. 
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Chapter 2: Structural basis for cofactor-independent 
dioxygenation:  crystal structure of DpgC bound to a stable 
substrate analog. 
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Introduction 
 Enzyme catalyzed oxidations are common reactions at all stages of natural 
product biosynthesis. From formation of precursors to tailoring of mature products, 
oxidation chemistry frequently imparts functionality important for structure and function. 
This is clearly exhibited in the vancomycin/teicoplanin family of antibiotics1. These 
glycopeptides function by binding the N-acyl-D-Ala-D-Ala termini of cell wall biosynthetic 
intermediates2. Their bactericidal capacity is due to the very oxidation events that shape 
these molecule’s cup-like architecture 3.  
 
  
  
 
 
 
 
 Glycopeptide antibiotics contain a core heptapeptide constructed by non-
ribosomal peptide synthetases (NRPSs), which are further processed by dedicated 
glycoslyases and oxidases (Figure 2-1). Enzymes from several classes including 
P450s4, non-heme iron5, and flavin-dependent enzymes6 perform transformations such 
as monooxygenations, dioxygenations, oxidations of alcohols to ketones, and the critical 
aryl-aryl crosslinking reactions found in this class of natural products. Several of these 
Figure 2-1.  Glycopeptide antibiotics vancomycin and teicoplanin. 
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redox enzymes are involved in the biosynthesis of the non-proteinogenic amino acids 
incorporated into the heptapeptide scaffold7. Of note, the biosynthesis of (S)-3,5-
dihydroxyphenylglycine (DPG) requires the use of the metal free, cofactor independent 
dioxygenase, DpgC8. 
  Five proteins, DpgA-D and HpgT, orchestrate the assembly of DPG starting from 
four units of malonyl-CoA (Figure 2-2). Work by the Pelzer laboratory established DpgA 
as a Type III polyketide synthase (PKS) capable of producing 3,5-dihydroxyphenylacetic 
acid using only malonyl-CoA9. Heterologous expression of DpgA-D in Streptomyces 
lividans led to production of 3,5-dihydroxyphenylglyoxylate(DPGX), demonstrating the 
involvement of all four enzymes in DPG biosynthesis.  The Walsh lab confirmed the 
activity of DpgA, and through careful in vitro characterization, they determined that 
DpgB&D increased the rate of formation of 3,5-dihydroxyphenylacetyl-CoA (DPA-CoA) 8. 
They also demonstrated that DpgC is an oxygenase, converting DPA-CoA to the 
glyoxylate DPGX. In the last step, a transaminase, HpgT, converts the glyoxylate to the 
amino acid product, 3,5-dihydroxyphenylglycine10. 
 
 
 
Figure 2-2.  Biosynthesis of the nonproteinogenic amino acid, DPG. 
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The cofactor-independent dioxygenase DpgC 
 Owing to its sequence homology with crotonase enzymes, DpgC was initially 
annotated as a dehydrogenase9. This was contradicted with data from the Walsh 
laboratory indicating DpgC was in fact an oxygenase, performing an overall  four-
electron oxidation and thioester hydrolysis8. This type of transformation is typically 
performed in PKS and fatty acid synthase pathways by three enzymes: a flavoprotein 
desaturase, an enoyl thioester hydratase, and an alcohol dehydrogenase11. The fact that 
DpgC performs this transformation without use of metals or cofactors places it into a 
small class of enzymes12, several of which were 
introduced in chapter one.  The uniqueness of this 
enzyme necessitated a more rigorous approach using 
labeling studies to examine the chemistry13.  Anaerobic 
incubation of the enzyme with substrate DPA-CoA in 
D2O followed by NMR and mass spectral analysis 
revealed that the protons at the C2-methylene (or 
alpha) position had been exchanged (Figure 2-3).  The 
rate of exchange of the first hydrogen was 14.2 min-1, 
which is comparable to the turnover rate of the enzyme 
(10 min-1). This suggests that enzyme-catalyzed, 
reversible enolate formation is an early step in the 
reaction pathway. Experiments measuring oxygen 
consumption with an oxygen electrode established not 
only the kinetic parameters of O2 (Km 1.0 ± 0.4 mM, kcat 
Figure 2-3. Labeling studies 
performed with DpgC 
establishing enolate formation 
and oxygen incorporation. 
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56 ± 18 min-1), but also that O2 was consumed in a 1:1 ratio with DPA-CoA. In order to 
confirm oxygenase activity, incubations of the enzyme with DPA-CoA and 18O2 were 
performed. With the use of proper controls, they adeptly demonstrated that both atoms 
of molecular oxygen are incorporated into the glyoxylate product, one in the C2-ketone 
and the other in the carboxylate (Figure 2-3). Incorporation of oxygen into the latter 
position establishes the coupled nature of oxygenation/thioester cleavage and indicates 
that hydrolysis is not the mode of CoASH release from DPA-CoA. 
 At this point, two potential mechanisms were proposed. Both involved initial -
deprotonation and enolate formation, consistent with biochemical data obtained from 
reaction incubations in D2O, and with bioinformatics indicating that DpgC is homologous 
to members of the crotonase superfamily9.  It is proposed that this C2-carbanionic 
species could then reduce O2 via a single electron transfer
14 which is comparable to the 
oxidizable substrates of other metal, cofactor-free oxygenases12.  
 Radical recombination to produce an -peroxy species could lead to the 
glyoxylate product via either a dioxetane intermediate15 or a Criegee-like 
rearrangement16 (Figure 4).  While valuable insight into the mechanism was obtained, a 
Figure 2-4. Two possible mechanisms for glyoxylate formation.  The upper pathway 
depicts a dioxetanone intermediate while the lower depicts a Criegee rearrangement. 
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detailed understanding of how the enzyme performs catalysis was not clear. Unresolved 
questions include: how does DpgC recognize and bind its substrate and molecular 
oxygen? DpgC’s homology to the crotonases suggests an oxyanion hole may be 
facilitating the chemistry. Since an enolate appears to be a viable intermediate, which 
residue is acting as the catalytic base? More importantly, how does the enzyme stabilize 
intermediates downstream of enolate formation? We sought to answer these questions 
by solving the X-ray crystal structure of DpgC. 
 
 
The DpgC apo structure 
Dr. Paul Widboom performed initial structural studies of DpgC. Heterologous expression 
of DpgC in E. coli followed by purification gave sufficient quantities of enzyme to obtain 
diffraction quality crystals. However, several attempts to solve the structure of DpgC, 
including molecular replacement, heavy atom soaking, and selenomethionine 
derivatization, all failed17. Utilizing site-directed mutagenesis, three of the ten 
methionines in DpgC were changed to leucines. Selenomethionine protein preparation 
and crystallization of these mutants produced crystals from which the structure could be 
solved using SAD (single-wavelength anomalous dispersion) phasing18.  This initial 
structure of DpgC was solved to a resolution of 2.75 Å in the R3 space group and an 
unusual crystal packing arrangement of four monomers (of the DpgC hexamer) present 
in the asymmetric unit. However, the structure was not of adequate quality for 
publication. Of the four monomers, one had very poor density and could not be 
completed beyond a polyserine backbone. In addition, an entire model could not be 
completed for the remaining three monomers, as there was little to no density for some 
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side-chain residues. While this model did not provide answers to all of our questions, it 
was informative about the overall architecture. Bioinformatic analysis revealed strong 
homology between DpgC’s C-terminal domain (280 of 430 amino acids) and the 
crotonase superfamily. This was validated by the DpgC apo-structure. An overlay of a 
monomer of 4-chlorobenzoyl-CoA dehalogenase, an archetypical crotonase, and DpgC 
shows the high level of three-dimensional similarity (Figure 5).  It is interesting to note 
that while the last ~70 residues of these two enzymes have similar secondary structure, 
the -helices are positioned differently. In 4-chlorobenzoyl-CoA dehalogenase, these 
residues are external to the main fold of the protein (orange, Figure 2-5). While in DpgC, 
this C-term portion folds back into protein (green, Figure 2-5) where some of these 
Figure 2-5. Structure of apo-DpgC monomer (left) with crotonase homology region 
indicated. On the right, an overlay of DpgC with 4-chlorobenzoyl-CoA 
dehalogenase (PDB #1NZY).  Homologous regions in wheat, crotonase C-term in 
orange, DpgC c-term in green, DpgC n-term in purple. 
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residues construct the oxygen binding pocket, as will be discussed later. We knew from 
the amino acid sequence that the N-term of DpgC is not homologous to any known 
sequences. The structure confirms these 160 residues do not align with a crotonase 
(purple, Figure 2-5), nor does this portion of the structure have any homology when 
searched with the DALI structural homology server19. Crotonases typically form a trimer 
via interactions of their N-terminal domains, which is then dimerized to form the 
hexameric biological unit 20. The four monomers of apo-DpgC observed in the R3 
asymmetric unit form a trimer via symmetry operations that overlays well with that of a 
crotonase. The remaining non-homologus N-terminus of DpgC sits on top of the trimer. 
We performed gel filtration chromatography and ultracentrifugation experiments to 
determine the quaternary structure of DpgC in solution21. As expected, the data was 
consistent with DpgC forming a hexamer (Figure 2-6).  
 In order to probe the function of the structurally unusual C-terminus of DpgC, we 
sought to make truncated constructs of DpgC lacking the non-homologous N-terminus. 
The truncations would begin with amino acids corresponding to 114 and 148 in wild-type 
Figure 2-6. The biological unit of DpgC is a hexamer. Gel filtration calibration curve 
(left) to estimate the Mw of DpgC as 354 kDa or 7.2 monomers. Kav is an elution 
volume parameter.   Standards  DpgC. DpgC sucrose-density gradient 
sedimentation (right). — BSA (67 kDa) — ADH (150 kDa) — ATCase (310 kDa) 
— thyroglobulin ( 669 kDa).  The molecular weight was estimated to be 258 kDa or 
5.3 monomers. 
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DpgC. This would allow us to determine if this region was necessary for catalysis. After 
several attempts to clone constructs beginning at amino acids Lys114 or Arg148, one 
plasmid for each truncated construct containing the appropriate gene was finally 
obtained. These plasmids were confirmed by sequencing, however, all efforts at 
heterologous expression of these truncated variants in E. coli, including altering growing 
and induction temperatures and times, failed. This lack of expression was confirmed via 
immunostaining of the hexa-histidine-tag (Figure 2-7) and it suggests that the N-terminal 
region is necessary for overall structure and folding of DpgC. 
 
 
 
  
  
  
 While we obtained useful information from this initial structure of DpgC, no 
knowledge of the active site could be procured with this model. Furthermore, a 
significant portion of the structure contained disordered loops, which suggested that a 
better model could be attained. The use of a stable substrate mimic or inhibitor could 
Figure 2-7. Gels indicating lack of protein production of N-
terminal truncated DpgCs.  Coomassie stained gel (left) and 
his-tag stained gel (right). 1L-E:his-tag protein purification from 
1L prep, UI: uninduced, I: induced, MW: broad range molecular 
marker, WT DpgC: wild type DpgC used as a standard. 
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help rigidify the enzyme and thus facilitate better crystal growth. If the active site is near 
the region of disordered loops, then a bound inhibitor may help to rigidify them.  
 
DPA-NH-CoA, an inhibitor of DpgC 
 Only an inhibitor that mimicked the substrate or reaction intermediate would 
provide a static glimpse of the enzyme in action. With the knowledge that an enolate was 
a early step in the chemistry, we reasoned that 
replacing the thioester in the substrate with an 
amide bond could provide an inhibitor meeting 
our requirements (Figure 2-8). This DPA-NH-
CoA compound would be isosteric to the 
natural substrate  (DPA-CoA) and thus should 
bind in the same fashion.  The distinction of the 
amide bond provides us with a non-
hydrolyzable substrate. DPA-NH-CoA could be 
made from a coupling of 3,5-
dihydroxyphenylacetic acid to an amino-CoA 
derivative.  Ye Liu in our group established the chemo-enzymatic chemistry necessary to 
synthesize amino-CoA22.  She also determined that DPA-NH-CoA was in fact a 
competitive inhibitor of DpgC with a Ki of  2.7 M23. 
 
Structural basis for cofactor independent dioxygenation 
 Initial experiments of soaking DpgC crystals with the inhibitor, DPA-NH-CoA, and 
co-crystallization in the previous obtained native conditions (95 mM HEPES-NaOH, 0.94 
Figure 2-8. Design of DpgC 
inhibitor DPA-NH-CoA 
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M sodium chloride, and 1.3 M ammonium sulfate, pH 7.5) failed to yield crystals.  It was 
necessary then to screen for new crystallization conditions in the presense of DPA-NH-
CoA.  After optimization of an initial hit from a matrix screen, suitable conditions for 
consistent production of diffraction quality DpgC/DPA-NH-CoA co-crystals were found 
(100 mM sodium citrate, 165 mM ammonium acetate, and 24% (w/v) PEG 4000, pH 
5.6). The phases of this enzyme-inhibitor complex were solved by molecular 
replacement with the program AMORE24.  A partial structure of a monomer of the native 
apo structure was used as the search model. This structure was solved to 2.45 Å in the 
P21212 space group and calculations predicted two trimers in the asymmetric unit 
(Matthews coefficient of 3.21 and 62% solvent content )23.  However, only one of the two 
trimers was built and refined, as electron density corresponding to the second trimer was 
weak and not interpretable. All crystals screened displayed this property. This ‘missing’ 
trimer could be the result of lattice-translocation defect25.  Simply put, the trimer 
occupied several overlying positions. Since the calculated electron density is an average 
of all the protein in the crystal, consistent, contiguous density will not be seen even 
though there was space in the asymmetric unit for this trimer. This problem is analogous 
to a structure that may have a loop with no density because it is highly dynamic, or the 
dynamic termini of proteins that often cannot be completely built. The later also occurs in 
our structure as the final model contains residues 11-432 in monomers A and B and 12-
432 in monomer C.  As a result of building half of the predicted model, the R-factors 
were uncharacteristically high at 2.45 Å resolution (Rworking=32% and Rfree=36%).  
Several attempts to correct this problem failed17. Despite this unfortunate anomaly, we 
are confident that the completed trimer (chains A-C) displays an accurate portrait of the 
enzyme and its active site. Electron density for this trimer is well defined (Figure 2-9), 
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including density for the inhibitor. In addition, all biochemical experiments performed 
based on the interpretation of this data indicates that the model is indeed a 
representative portrait of substrate bound to DpgC. The major bottleneck in this method 
of protein structure determination is obtaining diffraction quality crystals.  While methods 
are being developed that allow smaller and smaller crystals to be used26,27, the average 
crystallography lab aspires to produce crystals approximately 100-300 m in size. This 
can be very challenging criteria as numerous proteins have failed to yield crystals of this 
size or even have proven uncrystallizable28. The use of synthetic chemistry to produce 
stable substrate analogs or inhibitors can facilitate this process, and DpgC is a prime 
example. While determination of the apo-structure was plagued with problems that made 
obtaining any structure difficult, the DpgC/DPA-NH-CoA complex readily produced 
diffraction quality crystals. Not only did the inhibitor allow identification of the active site, 
but also several disordered loops around the active site were more ordered and could be 
completely built (Figure 2-10). 
Figure 2-9. Electron density map of DpgC. Sigma-
weighted composite omit map contoured at 2.0. An 
-helical section of DpgC around Tyr69 (right) and a 
-strand region around Glu365 (left) are shown. 
36  
Figure 2-10. Monomer of apo-DpgC (left) and the DpgC DPA-NH-CoA complex 
(right).  DPA-NH-CoA is shown in red. 
 
The active site of DpgC 
 The substrate DPA-CoA binds in a cleft on the surface of DpgC with the aromatic 
ring of the substrate tucked into the enzyme (Figure 2-11). The CoA portion of the 
substrate bends back on itself, with a hydrogen bond between the N7 of adenosine and 
the amide group of the pantetheine portion of DPA-CoA. As observed with other 
crotonase homologs, DpgC makes several specific interactions with the 3’-phospho, 5’-
diphosphoadenosine moiety of the substrate. For example, hydrogen bonds exist 
between the phosphates and Lys238, His277, and Tyr225 of DpgC. To confirm the 
necessity of the entire CoA moiety in substrate binding to DpgC, the truncated N-
acetylcysteamine thioester (DPA-SNAC, Figure 2-12) was prepared and assayed. N-
Acetylcysteamine analogues of CoA thioesters are used frequently as substrate mimics 
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for a variety of CoA and phosphopantetheinyl utilizing enzymes as these compounds are 
structurally analogous to the section of the substrate involved directly in the enzymatic 
reaction29,30. DpgC was incubated with concentrations of 
DPA-SNAC up to 3 mM; however, enzyme activity was 
not observed under any conditions. This confirms the 
necessity of the 3-phospho-5-diphosphoadenosine 
moiety of the substrate in the chemistry of DpgC.  
 The 3,5-dihydroxyphenyl ring is bound in a well-defined pocket with a hydrogen 
bond between the 5-hydroxyl and an ordered water molecule (W141, Figure 2-13).  The 
3-hydroxyl forms a hydrogen bond with Glu189 and interacts with the guanidine face of 
Arg254.  This is an unusual interaction as the phenolic oxygen is nearest (3.3 Å) to the 
epsilon  carbon of the Arg254 guanidinium group.  The carbonyl of the substrate mimic 
DPA-NH-CoA is positioned properly in an “oxyanion hole” (Gly296 and Ile235) similar in 
architecture to that previously described for other members of the crotonase 
superfamily31.  These interactions will be discussed in more detail in Chapter 3.  
Figure 2-11. Surface representation of DpgC showing binding 
pocket of DPA-NH-CoA (left) and molecular representation 
indicating bonding interaction between substrate and enzyme 
N
H
O
S
O
OH
HO
Figure 2-12. DPA-SNAC 
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 Once the inhibitor was built into the active site, all three monomers contained 
orphan electron density located directly above the substrate adjacent to the site of 
oxidation. The density was clearly larger than a water molecule and a model of dioxygen 
fits well (Figure 2-14). Ordered molecular oxygen is rarely observed in protein crystal 
structures, especially when it is not complexed to a transition metal32,33. The observed 
electron density, which we postulate to be bound oxygen, is in a well defined, solvent 
accessible hydrophobic pocket lined with side chain residues Leu237, Ile324, Val425, 
and Val429. There is a single hydrogen bond donor (backbone NH of Ile324) and no 
hydrophilic residues in the pocket. The size of the orphan electron density and the 
hydrophobic nature of the 
binding pocket suggest it is 
not bound water or a 
cationic metal. In addition, 
the crystallization media 
contained no compounds 
that could fit into the 
Figure 2-13. The active site of DpgC with proposed catalytic residues 
is shown. Yellow dashed lines indicate hydrogen bonds. 
Figure 2-14.  Electron density of DPA-NH-CoA and 
proposed O2 (left). Surface representation of the 
hydrophobic O2 binding pocket (right). 
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binding pocket. Thus, oxygen is the logical candidate for the unassigned electron density 
that we observe. However, we cannot say definitively, based on the electron density 
alone, that the orphan density is molecular oxygen.  One method to define oxygen 
binding pockets is the use of xenon gas as an isosteric mimic of O2
34,35,36. The co-
complex crystals were soaked under high pressures (up to 500 psi) of xenon gas, but 
the xenon failed to occupy the proposed oxygen-binding pocket.   
  With the ambiguous results obtained from the xenon gas experiments, we 
sought to further probe the nature of the hydrophobic pocket. Site-directed mutagenesis 
was utilized to subtly alter the hydrophobicity of the putative oxygen-binding site. The 
four hydrophobic residues(Leu237, Ile324, Val425, and Val429) (Figure 2-14) were 
individually changed to threonine, thus maintaining, in part, the hydrophobic character of 
the sidechains while adding an electronegative hydroxyl group.  These minor changes 
should disrupt oxygen binding and reduce enzyme activity.  As illustrated in Table 2-1, 
all four mutations affect the dioxygenase activity of DpgC as determined by the kcat/ KM 
values of DPA-CoA. Substrate turnover was 6% of the wild type mainly because of 
decrease in kcat.  The Michaelis constants (KM) of DPA-CoA, with the exception of 
L237T, are all within an order of magnitude of the wild-type. While enzyme activity is 
clearly hampered by these mutations, the results only indirectly suggest attenuated 
oxygen binding. 
 The kinetic parameters of O2 with the hydrophobic mutants were then measured 
with an oxygen electrode. Obtaining meaningful values with low error for this system was 
difficult as the ambient concentration of O2 in aqueous solution is ~300 M, while the 
determined KM is 1 ± 0.4 mM
13. It is difficult to measure points above the KM for O2 at 
atmospheric pressure. With this in mind, it is evident from a plot of the raw data that the 
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Table 2-1.  Steady-state kinetic parameters of DPA-CoA and O2 with hydrophobic pocket 
mutants. The units for KM(DPA-CoA) are μM, kcat are in min-1 and KM(dioxygen) are mM. ND, not 
determined. 
  DPA-CoA   O2  
Enzyme KM kca kcat/KM* KM(O2) kcat kcat/KM* 
WT 3.9 ± .60 10 ± 0.36 1 1.7 ± 0.7 127 ± 1 
Ile324Thr ND N/A  ND ND ND ± ND 
Leu237Thr 58 ± 33 2.9 ± 0.48 0.019 2.1 ± 0.8 103 ± 0.66 
Val425Thr 14 ± 7.2 2.2 ± 0.31 0.060 >2.6 ± 1 151 ± 0.4 
Val429Thr 15 ± 7.6 1.2 ± 0.48 0.029 2.6 ± 0.9 85 ± 0.4 
 
 calculated parameters denote real effects (Figure 2-15). Isoleucine 324 appears 
especially critical for enzyme activity since mutation to threonine abolishes activity 
(Table 2-1).  The Val425Thr construct appears to perturb O2 binding the most as the KM 
is more than doubled. Paul Widboom obtained a crystal structure of this mutant in order 
to 
Figure 2-15. Plot of initial velocity measurements versus concentration of 
dioxygen as measured with an oxygen electrode. 
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corroborate the biochemical data17.  The V425T structure was very similar to native 
DpgC, including the missing trimer and well-defined density in the active site of the three 
monomers present. Visible in this mutated structure is the lack of electron density 
attributed to O2 (Figure 2-16). This structure further bolsters the assignment of the 
orphan electron density to O2.  
 
 
 
 
 
 
 
 
 
 
Conclusion 
 The vancomycin biosynthetic enzyme DpgC belongs to a small class of 
oxygenation enzymes that are not dependent on an accessory cofactor or metal ion. The 
structure of DpgC represents the first of an enzyme of this oxygenase class in complex 
with a bound substrate mimic. DpgC is also the first example of an enzyme from the 
crotonase family that catalyzes oxidation/reduction chemistry. We utilized a designed, 
synthetic substrate analog, which enabled us to gain unique insights into the chemistry 
of oxygen activation. The structure confirms the absence of cofactors, and electron 
Figure 2-16. Comparison of electron density for WT DpgC (left) and Val425Thr 
DpgC(right), demonstrating the lack of O2 in the later. Composite omit maps.Wild-
type: 1.5, resolution 2.45A;Mutant: 1.5, resolution: 2.7A 
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density consistent with molecular oxygen is present in a small hydrophobic pocket 
adjacent to the site of oxidation of the substrate.  
 
Materials and Methods 
DpgC cloning and purification.  DpgC from the A47934 gene cluster was cloned from 
cosmid DNA (G. D. Wright, McMaster U.) into the NcoI and HindIII sites of the pET30a 
vector.  The vector was transformed into BL21(DE3) cells and grown in LB media at 
37oC until cell density reached O.D.=0.6.  Overexpression was induced by adding 50 
mM IPTG, followed by overnight incubation at 18 oC.  Cells were pelleted and lysed 
using a French Press system.  The enzyme was then purified with Ni-NTA affinity resin 
(Qiagen), followed by cleavage of the hexa-histidine tag with the protease enterokinase 
(3 days at 4 oC).  Further purification was performed with a HiTrap Q ion exchange 
column followed by a HiLoad 16/60 SuperDex 200 gel filtration column (GE 
Biosciences).  
Molecular Weight Determination. Initial determination of molecular mass was 
performed by gel filtration using a HiLoad 16/60 SuperDex 200 gel filtration column (GE 
Biosciences).  The standards for calibration were Blue Dextran (200 kD), Thyroglobulin 
(669 kDa), Alcohol Dehydrogenase (150 kDa), Bovine Serum Albumin (67 kDa), and 
Hen White Lysozyme (14.3 kDa). The molecular weight was determined to be ~354 kDa, 
which corresponds to ~7.3 monomers.   Additional molecular mass measurements were 
performed by sucrose-density gradient sedimentation using a Beckman L70 
ultracentrifuge and SW55Ti rotor. 200 L of a 5 mg/mL protein solution was layered on 
top of a 4.6 mL 6%–25% sucrose gradient in gel filtration buffer (20 mM Tris-HCl, 100 
mM NaCl, pH 7.5). The standards Bovine Serum Albumin (67 kDa), Alochol 
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Dehydrogenase (150 kDa), Aspartate Transcarbamoylase (310 kDa), and Thyroglobulin 
(669 kDa) were used for calibration. The gradients were centrifuged at 32,000 rpm for 20 
h at 10 °C and decelerated with no brake. On completion of the run, each sucrose 
gradient was fractionated. A 40% sucrose 1% bromophenol blue solution was drawn at 1 
mL/min into a Brandel BR-9620 fractionator by pump. The liquid was pumped from the 
fractionator to a 96 well microplate in 125 L fragments. The increase in absorbance at 
595 nm, caused by the presence of bromophenol blue, was used to determine the 
presence of protein. The molecular weight was found to be ~258 kDa or ~5.3 monomers 
of DpgC. 
DpgC N-terminal truncations. DpgC truncated constructs were cloned from a pET30a 
plasmid containing the gene dpgc. PCR amplification was performed using Deep Vent 
Polymerase (NEB Biosciences) and the following primers (restriction sites underlined): 
114-DpgC n-term, 5’-GAGCCATGGCTCGCGCCCTGGAG-3’; 148-DpgC nterm, 5’-
GAGCCATGGCTAAGGAGGGCCACGAGA-3’; DpgC c-term(for both constructs), 5’-
GCGGCGAAGCCTTCATGCGG-3’. Multiple attempts at inserting these DNA fragments 
into the NcoI and HindIII sites of the pET30A vector failed. The ratio of insert to vector 
was varied; the temperature of the ligation was varied (16 °C, 25 °C); solution and in-gel 
ligation was attempted. We then designed new n-term primers:  148-DpgC, 5’-
GCGCGCCATGGCTCGCGCCCTGGAGCTG-3’; 114-DpgC, 5’-
GCGCGCCATGGCTAAGGAGGGCCACGAG-3’ and used them to amplify the gene as 
previously.  Ligation again proved difficult, however, one colony for each construct was 
eventually obtained and confirmed by sequencing (GENEWIZ, NJ).  The vectors were 
transformed into BL21(DE3) cells and grown in LB media at 37 oC until cell density 
reached O.D.=0.6.  Overexpression was induced by adding 0.5 mM IPTG, followed by 
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overnight incubation at 18 oC.  Cells were pelleted and lysed using a French Press 
system.  The enzyme was then purified with Ni-NTA affinity resin (Qiagen).   It was 
evident from these gels that the protein was not being expressed.  This lack of 
expression was confirmed by growing 5 mL preps of the transformed cells at 37 °C for 
2hrs before induction with 0.5 mM IPTG.  Aliquots (20 μL) were separated on a 
denaturing agarose gel.  Prior to coomassie blue staining, any his-tagged proteins were 
fluorescently labelled using a his-tag staining kit from PIERCE (Figure 7).  These gels 
confirmed that no his-tagged proteins were being produced.  
Protein crystallization. Apo-DpgC (48 kDa, 439 amino acids) from the A47934 gene 
cluster37 was crystallized by the hanging-drop method at 20 ˚C.  DpgC (1.5 mL of 10 
mg/mL in 20 mM Tris-HCl and 50 mM NaCl, pH 7.5) was mixed with 1.5 mL of reservoir 
solution (95 mM HEPES-NaOH, 0.94 M NaCl, and 1.3 M (NH4)2SO4, pH 7.5).  Crystals 
appeared within two days and were allowed to continue growth for several additional 
days.  Crystals were transferred to a cryoprotectant solution of the reservoir solution with 
20% glycerol and soaked for 30 min before being flash frozen in liquid nitrogen.  
Cocrystals of DpgC with inhibitor DPA-NH-CoA formed under distinct conditions.  DPA-
NH-CoA (2 mM) was incubated with DpgC (12 mg/mL in 20 mM Tris-HCl and 50 mM 
NaCl, pH=7.5) at 20 ˚C for 2 hr.  The DpgC/inhibitor complex (1.5 L) was mixed with 
1.5 L of reservoir solution:  100 mM sodium citrate, 165 mM ammonium acetate, and 
24% (w/v) PEG 4000, pH 5.6.  Crystals appeared after two days at 20 ˚C.   Crystals 
were transferred to a cryoprotectant solution (reservoir solution with 20% glycerol) and 
soaked for 30 min before being flash frozen in liquid nitrogen. 
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Structural determination of DpgC/DPA-NH-CoA complex. All diffraction data were 
indexed, integrated and scaled using the HKL2000 program38. Model building was done 
using the program COOT39 and initial structure refinement performed with the program 
CNS40.  X-ray diffraction of the DpgC/inhibitor co-complex crystals was collected on the 
X26C beamline at Brookhaven National Labs.  Phases for the co-complex structure were 
calculated with the program AMORE using the incomplete native structure as a 
molecular replacement search model.  Initial structural refinement was performed with 
NCS restraints, and after several rounds the restraints were removed from the 
calculations.  Sigma-weighted simulated annealing composite omit maps (CNS) were 
used to judge and verify structures throughout refinement.   Based on examination of the 
asymmetric unit, two trimers are present (Matthews coefficient of 3.21 and 62% solvent 
content calculated for 6 monomers).  However, only one of the two trimers was built and 
refined as electron density corresponding to the second trimer was weak and not 
interpretable.    All crystals screened displayed this property.  As a result of building half 
the predicted model, the R-factors are characteristically high at 2.45 Å resolution 
(Rworking=32% and Rfree=36%).  The final model contains residues 11-432 in monomers A 
and B and 12-432 in monomer C.  The refinement statistics are listed in Table 2. 
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     Table 2. Data collection and refinement statistics 
   
Data collection Set Met apo-Dpgc Co-complex 
Space group R3 P 21 21 2 
Cell dimensions     
    a, b, c (Å) 138.7, 138.7, 239.7 139.9, 156.7, 
171.0 
    , ,   (°)  90.0, 90.0, 120.o 90.0, 90.0, 90.0 
Resolution (Å)  2.75 2.40 
Rsym or Rmerge 0.061 (0.714)* 0.130 (0.577) 
I/I 13.94 (2.47) 15.46 (2.55) 
Completeness (%) 98.4 (99.1) 98.0 (96.7) 
Redundancy 3.6 (3.6) 5.1 (4.4) 
   
Refinement   
Resolution (Å) 2.75 2.45 
No. reflections 88780 128559 
Rwork/ Rfree  .328/.356 
No. atoms   
    Protein  9797 
    Ligand/ion  180 
    Water  225 
B-factors   
    Protein  38.82 
    Ligand/ion  42.84 
    Water  32.83 
R.m.s deviations   
    Bond lengths (Å)   0.008 
    Bond angles (º)  1.4827 
  *Highest resolution shell is shown in parenthesis.  
 
 
Xenon Crystal Derivatives.  DpcC-inhibitor co-complex crystals were placed in a 
Xenon pressure chamber (Hampton Research) for a range of 5 to 45 min with pressures 
of 300 to 500 psi.  The xenon equilibrated crystals were flash frozen within seconds of 
removal from the xenon chamber.   
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DpgC HPLC Enzyme Assays.  Cloning, overexpression, and purification of DpgC 
follows protocol described above with one exception: the enzyme was purified only by 
affinity resin,  dialyzed into a common buffer (20 mM Tris-HCl, 50 mM NaCl, 20% 
glycerol, pH 7.5), flash frozen, and stored at -80 ˚C.  DPA-CoA (0.5 mM) was incubated 
with DpgC (2.5 μM) at 24 ºC (100 μL, 20 mM Tris·HCl pH 7.5) for 4 h.  The reaction was 
quenched with 1 μL TFA and products were analyzed by analytical C18 HPLC  (1 
mL/min; 0-3 min, 2% B; 3-43 min, 2-22% B, where A=0.05% TFA/H2O and B=0.05% 
TFA/CH3CN), monitoring at 260 and 220 nm.  
DPA-SNAC assays. DPA-S-(N-acetyl cysteamine) was synthesized using a published 
procedure30 and the crude product was purified via preparative HPLC using a Vydac  
C18 column (8 mL/min; 0-3 min, 10% B; 3-50 min 10-40% B, where A=0.1% TFA/H2O; 
B=CH3CN; DPA-SNAC eluted at 21.5 min), monitoring at 260 and 220 nm.  
Concentration by rotary evaporation and lyophilization gave DPA-S-(N-acetyl 
cysteamine) as a white powder. 1H NMR:  6.38 (d, 2H), 6.33 (t, 1H), 3.79 (s, 2H), 3.33 
(t, 2H), 3.03 (t, 2H), 1.8 (s, 1H); ES+ TOF MS:  292.6 (292.3 calc, C12H15NO4SNa).  
DPA-S-(N-acetyl cysteamine) (in varying concentrations, 0.5mM to 3.0 mM) was 
incubated with DpgC (2.5 μM) at 24 ºC (100 μL, 20 mM Tris·HCl pH 7.5) for 1 hr.  The 
reaction was quenched with 1 μL TFA and products were analyzed by analytical C18 
HPLC (1 mL/min; 0-3 min, 2% B; 3-40 min, 2-30% B, where A=0.1% TFA/H2O and 
B=0.1% TFA/CH3CN), monitoring at 260 and 220 nm. 
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DpgC kinetic assays. Kinetic analysis for DpgC was performed using the DTNB [5,5’-
dithiobis(2-nitrobenzoic acid)] reporter assay as described13 with one modification: the 
concentration of DpgC was 0.4 μM.  To determine the kinetic parameters of DpgC for 
substrate DPA-CoA, a freshly prepared solution of DTNB (1 mM), Tris·HCl (250 mM), 
and increasing concentrations of DPA-CoA was mixed with DpgC (0.4 μM) at 24 ºC (1 
mL).  The reactions were monitored in a UV-Vis spectrophotometer(Agilent 8453. Agilent 
Technologies: Santa Clara, CA) at 412 nm for 5 min. The observed initial rate of 
absorbance increase was converted to initial reaction velocity V0 (412nm=13,600 M-1·   
cm-1). 1/V0 was plotted as a function of 1/[S] according to Lineweaver and Burk.  Our 
measured KM was 4.7 μM and the kcat was 7.8 min-1 (similar to literature values: KM= 6 
μM, kcat= 10 min-1).   
Mutagenesis.  Point mutations of DpgC were made using the QuikChange Multi Site-
Directed Mutagenesis Kit (Stratagene: La Jolla, CA).  PCR amplification was performed 
using manufacturer provided QuikChange Reaction Buffer, QuikChange Multi enzyme 
blend and dNTP mix, along with the following primers and their reverse compliments 
(modified sequences underlined): I324T, 5’-GCG AAG GAG GGC ACC ATC CCG GGA 
GCC-3-’; L237T, 5’-AGC GCC GGC ATC AAC ACC AAG TAC CTC AGC CAG-3’; 
V425T, 5’-CTC TAC GGC CAC GAC ACG ATC GAC AAG GTC GGC-3’; V429T, 5’-
GAC GTG ATC GAC AAG ACC GGC CGA TTC GGA GGG-3’.  The PCR program 
consisted of an initial hold of 95˚C for 1 min followed by 30 cycles of 95 °C for 1 min, 55 
°C for 1 min, and 65 °C for 13.5 min.  The template DNA was digested with 10U of DpnI 
for 1 hour at 37 °C before transformation into XL10-Gold Ultracompetent Cells.  The 
mutagenesis products were confirmed by DNA sequencing (GENEWIZ: North 
Brunswick, NJ).  Kinetic parameters of the DpgC active site mutants were analyzed 
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using the DTNB reporter assay as described above with one modification: the 
concentration of the DpgC mutant was 0.186 μM.  
Measurement of kinetic parameters for dioxygen.  All enzymes were prepared for 
assays using the procedure described above.  O2 consumption was measured using a 
Clark-type O2 electrode (Hansatech Instruments) and the electrode signal was recorded 
using Virtual Bench Data Logger.  The electrode was calibrated using 2,3-
dihydroxybiphenyl and DHBD41. Data was collected every 0.003 s and initial velocities 
were determined from progress curves (Microsoft Excel).  Steady-state rate equations 
were fit to data using the least squares and dynamic weighting options of LEONORA42. 
The kinetic parameters of DpgC with respect to O2 were determined in 100 μM Dpa-CoA 
and varying concentrations of O2.  Reaction buffers (20 mM TrisHCl, 50 mM NaCl, pH 
7.5) at 25oC were prepared by bubbling mixtures of O2 and N2 gases for at least 5 min. 
The gases were mixed using a gas proportioner (Specialty Gas Equipment) and 
transferred to the reaction vessel using a Hamilton syringe.  The concentration of O2 was 
confirmed using the O2 electrode.  The assay was initiated by injection of enzyme (2 μM) 
into the reaction vessel containing buffer and Dpa-CoA (1 mL final volume).  The initial 
rates increased almost linearly with O2 concentration and no points above the Km could 
be obtained, causing low precision in the kinetic parameters.    
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Introduction 
 Protein crystallography has greatly improved our knowledge of how enzymes 
catalyze chemical transformations1.  This becomes abundantly clear when considering 
the example of ActVA-Orf6 discussed in chapter 1. Bioinformatic analysis had suggested 
a histidine residue was involved in catalysis and this hypothesis was supported by the 
fact that a His-Ala mutant had dimished activity2. The crystal structure of ActVA-Orf6 
revealed that the hisitidine was in fact, located at the dimmer inferface and not at the 
active site. The structure of the DpgC/DPA-NH-CoA complex described in the previous 
chapter provided a glimpse of the active conformation of the enzyme. In addition, 
observation of protein-bound oxygen allowed us to gain insight into the enzyme’s role in 
oxygen activation. Previously, catalytic mechanisms for DpgC had been proposed 3, but 
a detailed explanation of how the enzyme facilitated the chemistry was unclear.  
Examining the interactions between the substrate with active site residues allows one to 
propose a complete mechanism that can then be probed experimentally.  
 As described in chapter 2, we have solved a crystal structure of DpgC with a 
bound inhibitor, DPA-NH-CoA. An oxyanion hole was predicted to be present in DpgC 
due to its homology to crotonases and carbanion formation had been confirmed in 
biochemical emperiments3. 
Indeed, our structural 
characterization showed the 
carbonyl of the substrate 
thioester is located in an 
oxyanion hole, making hydrogen 
bond contacts to the backbone 
Figure 3-1. DPA-NH-CoA binding 
 in the active site of DpgC. 
A B 
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amides of Gly296 and Ile235 (Figure 3-1A). Interestingly, unlike other members of the 
crotonase family, no dedicated enzymatic base, such as histidine, was present in the 
active site to faciliate enolization. Instead, Glu299 appears to anchor a network of water 
molecules, with W258 (see Figure 3-1) properly positioned to shuttle a proton from the 
!-position of the substrate. This is chemically reasonable as the oxyanion hole should 
sufficiently acidify the ! proton4.  
Residues that make contacts to the aryl ring of the substrate DPA-CoA include 
Arg254, Glu189, and Glu255 (Figure 3-1B). The bifurcated hydrogen bond between 
Arg254 and Glu189 with the 3-hydroxyl appears particularly important, as this interaction 
is predicted to stabilize the build-up of negative charge on the aromatic ring.  Taken with 
the negative charge resulting from enolate formation, a substrate dianion could serve as 
a sufficient reductant, transferring an electron to molecular oxygen and forming 
superoxide. An overall transformation of this type of transformation is analogous to 
chemistry performed by other cofactor-free oxygenases5 and flavoenzymes6.  At this 
Figure 3-2.  Proposed catalytic mechanism of DpgC. 
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point in the catalytic cycle, radical recombination to form the peroxidate, expulsion of 
CoA to form the dioxetenone, and collapse to the glyoxylate could occur. Our proposed 
mechanism is outlined in Figure 3-2. 
 
Probing substrate determinants of DpgC. 
 Our investigations into the proposed mechanism of DpgC began with the 
preparation of alternate substrates. Various phenylacetyl-CoA analogs were synthesized 
and assayed against the wild-type enzyme in order to examine the role played by 
substrate functional groups in the chemistry of DpgC.  In particular, the impact of the two 
symmetric phenolic hydroxyl groups (refered to as 3-OH and 5-OH) of the substrate was 
probed. The use of mono-hydroxy and des-hydroxy analogs would be a quick way to 
analyze the significance of this functionality and indirectly probe the importance of side-
chain interactions with this portion of DPA-CoA. Synthesis of these phenylacetyl-CoA 
substrates was accomplished by PyBOP coupling of the corresponding phenylacetic 
acid to CoA. Enzyme activity with these substrates was then tested using both HPLC 
and the DTNB assay for free thiols7. In general, as shown in Table 3-1, DpgC has the 
ability to process a diverse range of substituted phenylacetyl-CoA substrates. The 
results of these assays indicate that at least one hydroxyl is necessary to maintain a 
catalytic rate on par with the natural substrate. Removal of one of the hydroxyl groups 
from the natural substrate (3-hydroxyphenylacetyl-CoA) had little effect on the activity of 
the enzyme both in terms of the measured kcat and KM.  However, phenylacetyl-CoA 
(entry 3, Table 3-1) was less efficiently processed by DpgC.  in addition, repositioning a 
hydroxyl to the 4-position (4-hydroxyphenylacetyl-CoA, entry 4) gave a substrate that 
was still turned over by the enzyme, but with much lower efficiency
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 (as measured by the relative kcat/KM values).   Interestingly, this substrate analog had a 
substantially weaker KM but a kcat similar to the natural substrate.   The presence of a 4- 
hydroxyl group could influence the electronics of the enzyme-bound enolate by 
increasing the electron density at the benzylic position and facilitating the downstream 
reaction with molecular oxygen despite the large negative affect on substrate binding.  
In order to provide a structural basis for substrate binding, amide analogs were 
synthesized and used for co-crystallization. Crystals of the co-complexes between DpgC 
and both phenyl and 4-hydroxyphenylacetyl-NH-CoA were grown and the structures 
determined. Electron density corresponding to these analogs, however, was difficult to 
interpret and the phenyl rings appeared to be bound in multiple conformations. The 
results from the kinetic experiments with alternate substrates suggested that the 
 
Table 3-1. Kinetic parameters for alternate DpgC Substrates 
 
HO
OH
1
2
3
4
entry substrate KM (µM) kcat (min
-1) kcat/KM*
3.9 ± 0.6!
4.4 ± 1.4
102 ± 37
!
851 ± 361
10.32!± 0.36
7.52!± 0.57
3.84!± 0.36
!
13.32!± 2.33
1 
0.650
0.014
0.006
O
S-CoA
HO
O
S-CoA
O
S-CoA
O
S-CoA
HO
(1.022)
(0.558)
 
 *Relative apparent second-order rate constants. Measurements performed with 
 oxygen-saturated buffer are shown in parentheses. 
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Arg254/Glu189 interactions were of particular importance to catalysis. We therefore 
turned our attention to mutagenesis of the enzyme to probe the role of these residues. 
 
Mutagenesis of active site residues 
  Rationally changing residues in an enzyme active site is a useful approach to 
determine specific roles in catalysis. Replacing a potential catalytic residue with alanine 
is a way to “knock out” an enzyme’s activity and confirm the necessity of the residue. In 
our investigation of the active site residues of DpgC, we chose to make subtle changes, 
incorporating residues that should maintain the structural integrity of the active site while 
simultaneously altering the enzyme’s catalytic capability.  
 The oxyanion hole is no doubt critical for catalysis, as an early step in the 
catalytic cycle of DpgC is likely the formation of a thioester enolate8,9. The backbone 
amides of residues Gly235 and Ile296 are properly oriented to fulfill this role. As main-
chain atoms are involved in this interaction, no reasonable substitutions for these 
residues can be made through standard approaches toward site-directed mutagenesis. 
As mentioned, no amino acid derived general-base exists in the active site to directly 
participate in the deprotonation of an !-hydrogen in the substrate. There is, however, an 
ordered water molecule positioned adjacent to the oxyanion-hole-acidified benzylic 
hydrogen (Figure 3-3).  As predicted with other crotonase family members, catalysis in 
DpgC is driven by the stabilization of thioester enolate through tight binding interaction. 
For example, coenzyme A acyl thioesters bound to the enoyl-CoA hydratase have a 
measured pKa of ~8.5
10. The substrate of DpgC contains an additional !-phenyl ring that 
will further lower the pKa of the substrate. Taken together, the pKa of DPA-CoA bound in 
the active site of DpgC can be estimated to be < 7.5 and therefore a specific enzyme-
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associated base is not 
necessary.  The role of the 
network of waters anchored 
by Gln299 could function to 
provide a mechanism to 
shuttle the two protons 
produced during the catalytic 
cycle to bulk solvent (Figure 3-3). In order to test this hypothesis, the mutant Gln299Asn 
was constructed and biochemically characterized.  The change resulted in a 2-fold 
reduction to the overall kcat/KM as compared to the wild-type enzyme (Table 3-2).  This 
effect was largely a consequence of a decrease in the rate of catalysis, supporting the 
importance of the structurally observed water molecule in facilitating the formation of the 
thioester enolate.  
 Glutamate 255 forms the only observed interaction with the 5-hydroxyl of DPA-
CoA (5-OH, Figure 3-3) through an intervening water molecule.  Mutation of this 
carboxylate-containing residue to glutamine (a carboxamide) resulted in an enzyme that 
retains similar activity as the wild-type (Table 3-2), suggesting specific recognition of the 
5-OH is not important for enzyme function.  This data corroborates what we had 
determined previously using a mono-hydroxyl substrate derivative. Our attention was 
then turned to what appeared to be the crucial interaction of the 3-OH (3-OH, Figure 3-
3) with two active site side chains (Arg254, Glu189). We hypothesized that these two 
residues contribute to a build-up of negative charge on the ring, facilitating electron 
transfer to O2. Mutation of either Arg254 or Glu189 had a pronounced affect on the 
activity of the enzyme. The sterically conservative mutation Glu189Gln had a measured 
Figure 3-3. Active site contacts of DpgC with DPA-NH-CoA 
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KM value ~20 times higher than the wild type enzyme, indicating that the anionic side 
chain of Glu189 is important for substrate binding. We envisioned that an Arg254Lys 
construct would place a positively charged, hydrogen bond donor (-NH3
+) in a position to 
interact with the 3-OH as observed with the guanidinium of Arg254. This could provide 
insight into whether only a hydrogen bond donor was necessary or if there was more to 
the (unprecedented) 3-OH - Arg"C interaction. Enzyme activity was practically 
abolished, mainly due to the dramatic affect on the Michaelis constant, suggesting that 
the substrate binds with ~50 times lower affinity. This result suggests that the unusual 
face-on interaction with arginine is indeed imperative. Its possible that Arg254 is both 
acidifying the 3-OH, allowing Glu189 to act as a base, and also stabilizing the resulting 
anion. Both mutations had only a modest effect on enzyme turnover rate, with activity 
measured at approximately half the rate of wild-type DpgC. The presented 
measurements were 
conducted under 
physiologically relevant, 
ambient oxygen 
concentrations. In order 
to assess the effect 
oxygen concentration 
has on the kinetics, 
measurements were 
also performed in 
oxygen saturated 
buffers.  In all cases, 
*Relative apparent second-order rate constants. Measurements 
performed with O2-saturated buffer are shown in parentheses.  
 
 
Table 3-2  Kinetic parameters of DpgC mutants with DPA-CoA. 
enzyme KM (µM) kcat (min
-1) kcat/KM*
Wild-Type
Arg254Lys
Glu189Gln
Glu255Gln
Gln299Asn
3.9 ± 0.6 10.32 ± 0.42 1
217 ± 46
64 ± 13
3.6 ± 1.9
2.5 ± 1.1
5.17 ± 0.32
5.12 ± 0.41
9.18 ± 0.78
4.14 ± 0.21
0.009
0.029
0.959
0.619
(1.022)
(0.014)
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the increase in oxygen concentration had little affect (within 2%) of the measured kcat/KM 
at 1 atm oxygen concentration (Table 3-2).   
 The substantial change in activity of the Arg254Lys mutant warranted further 
investigation to determine if the decrease in activity was only due to dissolution of a 
crucial interaction and not a disbanded active site or a global structural change. The 
most direct method to answer this question was to obtain a crystal structure. We 
therefore  solved the X-ray crystal structure of the Arg254Lys construct bound to the 
substrate analog DPA-NH-CoA (PDB #2PG8). This complex crystallized under the same 
conditions and with the same space group symmetry as the wild-type enzyme complex. 
The structure was solved to 3.0 Å using phase information from the native complex 
(PDB #2NP9) and the lysine mutation was built into the model. Despite sub-optimal 
resolution, we were able to obtain well-formed electron density maps, including the 
active site residues and DpA-NH-CoA (Figure 3-4). The overall structure deviates very 
little from the wild-type enzyme (RMSD over all atoms = 0.52 Å). The substrate analog is 
bound in the same orientation as observed for the wild type enzyme and electron density 
consistent with molecular oxygen is evident adjacent to the substrate analog. The 
ammonium group of lysine is positioned to make a favorable electrostatic interaction with 
Figure 3-4.  A) Electron density map of the R254K construct of DpgC. B) Side-by-side 
representation of R254K and WT DpgC demonstrating the validity of the R254K active site. 
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the 3-OH of the substrate. Though the distance (3.3 Å) and geometry are not optimal to 
make a hydrogen bond, no constraints are evident in the structure to prevent its 
formation. The results confirm that the specific chemical orientation of the arginine is 
important for activity and the observed interaction in the wild-type enzyme more than just 
simple hydrogen bonding. The lysine of Arg254Lys DpgC is not, however, in position to 
hydrogen bond with Glu189 as the arginine is in the wild-type structure (Figure 3-4).  
The Arg254/Glu189 dyad plays an important role in catalysis and together are the major 
determinants for binding the 3,5-dihydroxyl ring of the substrate.  
 Using a combination of X-ray crystal structures, site-directed mutagenesis, and 
alternate substrate kinetics, we have gained significant knowledge on the initial steps in 
the proposed enzymatic mechanism of DpgC (Figure 3-2). However, initial crystal 
structures did not give us sufficient information to decipher the downstream steps. 
Different methods would have to be employed to work out these mechanistic details. Our 
attempts to answer these questions will be discussed in the next chapter. To date, these 
steps have not been experimentally defined for any of the cofactor-free oxygenases.  
 
 
Materials and Methods 
Site-directed mutagenesis.  Amino acid point mutations of DpgC were made using the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene: La Jolla, CA).  DpgC from the 
Streptomyces toyocaensis A47934 gene cluster cloned into the vector pET30a was used 
as the template.  PCR amplification was performed following the manufacturer’s protocol 
with the following primers and their reverse compliments (modified sequences 
underlined):  Glu189Gln, 5’-CGC CTG AAC GCC CAG GAC GGT CAG CAG-3’; 
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Arg254Lys, 5’-GTC GAC TTC CTG ATG CGC AAG GAA CTC GGC TAC-3’; 
Glu255Gln, 5’-TTC CTG ATG CGC CGG CAA CTC GGC TAC ATC-3’; Gln299Glu, 5’-
GGC GGC GGA GCC AAC TTG CTG CTG GTC-3’.  The oligonucleotides were 
synthesized by Integrated DNA Technologies (Coralville, IA). The PCR program 
consisted of an initial hold of 95 ˚C for 1 min followed by 30 cycles of 95 °C for 1 min, 55  
°C for 1 min, and 65 °C for 13.5 min.  The template DNA was digested with 10U of DpnI 
for 1 hour at 37 °C before transformation into XL10-Gold Ultracompetent cells.  The 
mutagenesis products were confirmed by DNA sequencing (GENEWIZ, NJ).  
DpgC Mutant Expression and Purification.  BL21(DE3) E. coli cells were transformed 
with mutant vectors and grown in LB media at 37 oC until cell density reached 
OD600=0.6.  Overexpression was induced by adding IPTG (50 mM), followed by 
overnight incubation at 18 oC.  Cells were pelleted using centrifugation and lysed using a 
French Press system.  The enzymes were then purified with Ni-NTA affinity resin 
(Qiagen), dialyzed into a common buffer (20 mM Tris·HCl, 50 mM NaCl, pH 7.5), 
concentrated, flash frozen in buffer with 20% glycerol and stored at -80 °C.  
Enzyme activity assays. Kinetic analysis for DpgC mutants was performed using the 
DTNB [5,5’-dithiobis(2-nitrobenzoic acid)] reporter assay as described11 with one 
modification: the concentration of DpgC mutants used was 0.19 µM.  To determine the 
kinetic parameters of DpgC mutants for substrate DPA-CoA, a freshly prepared solution 
of DTNB (1 mM), Tris·HCl pH=7.5  (250 mM), and increasing concentrations of DPA-
CoA was mixed with DpgC (0.19 µM) at 24 ºC (100 mL).  The reactions were continually 
monitored with a UV-VIS spectrophotometer at 412 nm for 5 min.  For oxygen-saturated 
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buffer assays, conditions were identical to those described above with the exception that 
oxygen gas was rigorously bubbled through the buffers for 5 minutes. 
Synthesis of DPA-CoA Substrate Analogs. 1H NMR spectra were recorded using a 
Varian Unity 400 MHz (400 MHz) spectrometer.  Chemical shifts are reported in ppm 
from trimethylsilane with the solvent as the internal standard (CDCl3: # 7.26 ppm, D2O: 
# 4.80 ppm).  Data are reported as follows:  chemical shift, (multiplicity [singlet (s), 
doublet (d), triplet (t), quartet (q) and multiplet (m)], integration, and coupling constants 
[Hz]. The general coupling procedure of the phenylacetic acid derivatives with coenzyme 
A follows published procedures for the synthesis of substrate DPA-CoA 3,11.   
Phenylacetyl-CoA. Potassium carbonate (7 mg) was added to a solution of phenylacetic 
acid (4.4 mg, 2.5 eq), PyBOP (16.9 mg, 2.5 eq),  and CoA (10 mg, 1 eq) in 1 mL of 1:1 
THF:H2O.  The reaction was stirred for 2 hrs at room temp followed by acidification with 
100 mL of TFA.  The solution was flash frozen in liquid N2 and lyophilized to dryness. 
The crude product was purified by preparative HPLC using a Vydac 218TP1022 C18 
column (8 mL/min; 0-3 min, 2% B; 3-40 min 5-20% B, where A=0.1% TFA/H2O; B= 
CH3CN; phenylacetyl-CoA eluted at 36 min), monitoring at 260 and 220 nm.  Removal of 
the solvents by lyophilization gave phenylacetyl-CoA as a white powder (9 mg, yield 
80%).  Compounds were stored at -20 oC.  1H NMR: # 8.61 (s, 1H), 8.35 (s, 1H), 7.25 
(overlapping m, 5H), 6.16 (d, 1H), 4.58 (overlapping m, 3H),  4.62 (br s, 1H), 3.91 (s, 
1H),  3.85 (d, 1H), 3.70 (m, 4H),  3.60 (d, 1H), 3.28 (m, 4H), 2.96 (t, 2H), 2.23 (t, 2H), 
0.92 (s, 3H), 0.79 (s, 3H); ES- TOF MS: 907.2 (907.5 calc, C29H41N7O17P3SNa).   
4-Hydroxyphenylacetyl-CoA. HPLC purification: (8 mL/min; 0-3 min, 2% B; 3-40 min 2-
20% B, where A=0.1% TFA/H2O; B= CH3CN; 4-Hydroxyphenylacetyl-CoA eluted at 35 
min) 1H NMR: # 8.64 (s, 1H), 8.39 (s, 1H), 7.11 (d, 2H), 6.77 (d, 2H), 6.19 (d, 1H), 4.88 
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(overlapping m, 4H), 4.60 (br s, 1H), 4.27 (br s, 2H), 4.02 (s, 1H), 3.87 (m, 1H), 3.61 (m, 
1H), 3.78 (overlapping m, 4H), 3.33 (overlapping m, 4H), 2.99 (t,  2H), 2.26 (t, 2H), 0.93 
(s, 3H), 0.79 (s, 3H) ; ES- TOF MS:  923.2 (923.5 calc, C29H41N7O18P3SNa). 
 3-Hydroxyphenylacetyl-CoA. HPLC purification: (8 mL/min; 0-3 min, 2% B; 3-40 min 2-
20% B, where A=0.1% TFA/H2O; B= CH3CN; 3-Hydroxyphenylacetyl-CoA eluted at 37 
min) 1H NMR: # 8.61 (s, 1H), 8.36 (s, 1H), 7.15 (t, 1H), 6.76 -6.70 (overlapping m, 3H), 
6.17 (d, 1H), 4.88 (overlapping m, 4H), 4.60 (br s, 1H), 4.28 (br s, 2H), 4.00 (s, 1H), 3.87 
(m, 1H), 3.81 (s, 1H), 3.71 (overlapping m, 4H), 3.61 (m, 1H), 3.30 (overlapping m, 4H), 
2.98 (t,  2H), 2.26 (t, 2H), 0.92 (s, 3H), 0.79 (s, 3H) ; ES+ TOF MS:  923.2 (923.5 calc, 
C29H41N7O18P3SNa). 
Crystallization, Data Collection, and Structure Determination. Arg254Lys-DpgC (48 
kDa, 439 amino acids) was co-crystallized with the substrate analog DPA-NH-CoA by 
the hanging-drop method at 20 °C. DPA-NH-CoA (2 mM) was incubated with 
Arg254Lys-DpgC (12 mg/mL in 20 mM Tris·HCl and 50 mM NaCl, pH=7.5) at 20 °C for 2 
hr.  The DpgC/ DPA-NH-CoA complex (1.5 mL) was mixed with 1.5 mL of reservoir 
solution:  100 mM sodium citrate, 150 mM ammonium acetate, and 15% (w/v) PEG 
4000, pH 5.6.  Crystals appeared after two days at 20 °C.  Crystals were transferred to a 
cryoprotectant solution (reservoir solution with 20% glycerol) and soaked for 30 min 
before being flash frozen in liquid nitrogen. Diffraction data were collected to 3.0 Å at the 
X12C beamline of the National Synchrotron Light Source (NSLS) at Brookhaven 
National Labs.  Diffraction data were processed and scaled with the program package 
HKL2000 (35).  The crystal structure was solved by molecular replacement using the 
program CNS (36) with native DpgC as the search model (PDB entry #2NP9). 
Refinement of the structure was performed with NCS restraints using program CNS.  As 
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with the wild-type structure, only three of the six monomers were ordered in the crystal 
resulting in an Rworking= 0.33 and Rfree= 0.36 (15). The program PyMOL (Delano 
Scientific, San Carlos, CA) was used to generate graphic images.  The refinement data 
are shown in Table 3-3. 
 
  Table 3-3. Data collection and refinement statistics  
   
Data collection R254K DpgC 4HPA-NH-CoA/DpgC 
Space group P21212 P21212 
Cell dimensions     
    a, b, c (Å) 139.0, 155.3, 169.2 141.4, 155.2, 179.4 
    !, ", #  (°)  90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Resolution (Å) 3.00 2.9 
Rsym or Rmerge 0.116 (0.593)* 0.262 (0.444) 
I/$I 7.4  
Completeness (%) 99 95 
Redundancy 9.8 3.2 
   
Refinement   
Resolution (Å) 3.0 3.0 
No. reflections 69142 68887 
Rwork/ Rfree 0.331, 0.367 0.276, 0.3158 
No. atoms   
    Protein 9619  
    Ligand/ion 177  
    Water 123  
R.m.s deviations   
    Bond lengths (Å)  0.010 (0.008)  
    Bond angles (º) 1.5 (1.4827)  
   *Highest resolution shell is shown in parenthesis.  
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Chapter 4: Probing the electron transfer steps catalyzed by 
DpgC. 
 72 
 
 
Introduction 
As introduced in Chapter 1, enzymes are proficient at harnessing the oxidizing power of 
O2. DpgC belongs to a small class of enzymes that do not require an auxiliary metal or 
cofactor to perform chemistry with triplet O2. We proposed, similar to other systems, that 
the substrate for DpgC itself acted as the reductant to form superoxide (O2) starting the 
cascade to downstream chemistry. Binding of DPA-CoA in the active site induces 
dianion formation via an enolate stabilized by the oxyanion hole and a phenoxide by an 
Arg254/Glu189 diad. The negatively charged substrate could then transfer a single 
electron to O2 to form superoxide. Experimental validation of this step is not a trivial task. 
Previous experiments, designed to detect reactive oxygen species (ROS) and support a 
radical intermediate, had shown that DpgC does not leak any ROSs such as superoxide 
or H2O2
1. In another member of the small family of cofactor independent dioxygenases, 
Hod, the use of electron paramagnetic resonance (EPR) in a model chemical system 
showed that a resonance-stabilized radical could be formed on the substrate when 
exposed to dioxygen and catalytic amounts of base. However, EPR studies of the 
substrate with the enzyme itself failed to produce evidence of a radical mechanism2. 
Nevertheless, a radical intermediate could still be forming as a caged radical pair is 
predicted, and this species is not detectable by EPR. A similar scenario can be proposed 
for DpgC. We chose two strategies to probe the potential radical mechanism of DpgC. 
The first employs the use of a cyclopropyl derivative of the substrate that would undergo 
a rearrangement upon radical formation, a so-called radical clock, and thus provide a 
handle for detection. The second method involves installation of a cysteine residue in the 
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proximity of the active site. If superoxide is formed, this species could potentially be 
trapped via oxidation of the sulfur atom of the cysteine residue.  
 
Cyclopropyl radical-probe substrates 
 Cyclopropyl substrate analogs have been used for decades to probe radical 
mechanisms in chemical and enzyme reactions3,4,5,6,7. An example is given in Figure 4-
1. If a radical is formed, a rearrangement can occur involving opening of the cyclopropyl 
ring. The ring-opening rates of some of the hypersensitive radical clock probes (~1011s-1) 
allow detection up to the limit for a barrier-less decomposition of a transition state 
(6x1012 s-1)8,9. Typically, these ultra-fast probes incorporate radical stabilizing groups, 
such as an aromatic ring and the rates of these probes involve cyclopropylcarbinyl 
radical formation. There are 
limited examples of radical 
clocks specific for the 
benzylic position5, an 
example of which is shown in 
Figure 4-1. We designed and 
synthesized DPA-CoA cyclopropyl substrate derivatives to probe the electron transfer 
step. A single electron oxidation will produce a radical species capable of opening the 
cycloproyl ring, the product of which will be detectable using standard NMR and LCMS 
based analysis. As outlined in Figure 4-2, solvent, oxygen, or even an amino acid side 
chain could modify the free radical resulting from ring opening. In the case of covalent 
attachment of the substrate to DpgC, tandem mass-spec experiments can be used to 
determine the site and nature of the modification.  
Ph
CH3
-H
Ph
CH2
Ph
CH2
k = 1.8 x 1011
Ph
Ph Ph
Ph
k = 3 x 108
Figure 4-1. The ring opening mechanism of a radical 
clock. A benzylic radical clock (bottom). 
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 Three cyclopropyl probes were prepared from a coupling of the corresponding 
phenylacetic acid derivatives to CoA (Figure 4-3). The cyclopropyl moiety was 
positioned para to CoA as the site of oxidation is 
at the benzylic position (Figure 4-2) and the 
substitution pattern of hydroxyls on the aromatic 
ring was varied. As substrate binding and active 
site sterics could impact the efficacy of the probe, 
so multiple substrate derivatives were designed. 
Scheme 4-1 outlines the synthetic scheme for, 4- 
cyclopropylphenyl acetic acid (4.1).  Compound 
4.1 is prepared from vinyl benzyl chloride 4.4. A one carbon homologation10 gives para-
vinylphenyl acetate 4.5, which is then subjected to a Simmons-Smith cyclopropanation11. 
Saponification yields the acid 4.6, which can then be coupled to CoA to give product 4.1.  
 
 
Figure 4-2.  Potential products of incubation of enzymatic reactions. 
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Figure 4-3.  Cyclopropyl substrates. 
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The synthetic route to 4-cyclopropyl-3-hydroxyphenylacetyl CoA (4.2) had precedent in 
the patent literature12 and begins with 3-hydroxyphenylacetic acid (Scheme 4-2, 4.7).  
After conversion to a methyl ester, bromination of the aromatic ring (4.8) and TBS 
protection of the alcohol sets the stage for a Suzuki cross-coupling with cyclopropyl 
boronic acid13,14,15 (4.9). Saponification and deprotection, followed by PyBOP coupling of 
CoA gave 4.2.  
 
 
Scheme 4-2. (a) SOCl2, MeOH, rt, 2 hr, 99%; (b) Br2, (CH3)3CNH2, 2:1 
Tolulene:DCM, -30 °C 0.5 h, -78°C to rt 16 h, (c) TBDMSCl, TEA, 
DMAP, DCM, rt, 0.5 h, 79%; (d) Pd(OAc)2, PCy3, K3PO4, Cyp-B(OH)2, 
Tolulene, 100°C, 5 h, 94%; (e) TBAF, THF, rt, 1 h, 69%; (f) LiOH, EtOH, 
1:1 MeOH:H2O, 0°C - rt, 16 h, 67%; (g) PYBOP, CoA, K2CO3 
OH
OTBS
OH
CO2Me
S-CoA
OCO2
-
OH
CO2Me
Br
a, b c, d e, f, g
4.7 4.8 4.9 4.2
Scheme 4-1.  (a) 18-Cr-6, KCN, CH3CN, rt, 100%.  (b) KOH, EtOH, 80 
o
C, 16 h, 84%.  
(c) NaHCO3, DMS, acetone, 60 
o
C, 16 h, 64% (d) CH2I2, Et2Zn, DCM, 0 
o
C to rt, 12 h, 46%.  
 (e) LiOH, 3:1 MeOH:H2O, rt, 2 h, 40%  (f) CoA, PyBop, K2CO3, 1:1THF:H2O, rt, 2 h, 39% 
Cl CO2Me
a,b,c d,e
CO2H
f O
SCoA
4.14.64.54.4
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Synthesis of the dihydroxy-cyclopropyl derivative proved tricky. Several attempts at 
deprotecting 4-cyclopropyl-3,5-dimethoxy-methylphenyl acetate16,17 led to cyclopropyl 
ring-opening and decomposition of the product.  In order to alleviate this issue, we 
decided to protect the phenol hydroxyls as TBS-ethers. Therefore the synthesis of 4.3 
started with demethylation of 4-bromo-3,5-dihydroxybenzoic acid (4.10) followed by 
protection of the alcohols as the TBS-ethers. Treatment with thionyl chloride activated 
the acid (4.11) for an Arndt-Eistert homologation (4.12). The rest of the synthesis follows 
the steps outlined for 4.2, with a Suzuki coupling, deptrotection, and coupling to CoA to 
yield 4.3.    
 
 Most of the assays were performed with 4.1, as its synthesis was completed first. 
As 4.2 and 4.3 have been completed recently, assay conditions are currently being 
developed. An HPLC assay was performed to determine if 4.1 was turned over by the 
enzyme. The experiment suggested that hydrolysis of the thioester was occurring 
without oxidation at the benzylic position as two peaks are observed with retention times 
Scheme 4-3. (a) 2.5 eq. BBr3, DCM, 0 °C - rt, 3 h, 62%; (b) 4 eq. TBDMSCl, 4 eq. 
TEA,  0.5 eq. DMAP, DCM, rt, 5 h, 94%; (c) C2O2Cl2, DMF, CH2Cl2, rt, 3 h, 75%;  
(d) 2 eq. TMS-CH-N2, 1:1 THF:CH3CN, 0 °C - rt, 16 h, 70%; (e) 0.2 eq. AgC6H5CO2, 
4 eq. TEA, MeOH, rt, 77%; (f) 0.05 eq. Pd(OAc)2, 0.1 eq. PCy3, 3.5 eq. K3PO4, 1.2 
eq. Cyp-B(OH)2, Tolulene, 100 °C, 3 h, 65%; (g) 2 eq. LiOH, MeOH, 1:1 
MeOH:H2O, 0 °C - rt, 3 h, 67%;(h) 2 eq. TBAF, THF, rt, 3 h, 69%;  (i) PYBOP, CoA, 
K2CO3 
OMe
a, b,c
MeO
Br
O OH
OTBSTBSO
Br
O Cl
4.10 4.11
OTBSTBSO
OMe
O
d, e, f
OHHO
S-CoA
O
g, h, i
4.12 4.3
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equivalent to standards of CoA and 4.6 (Figure 4-4). These HPLC assays are performed 
on a small scale (100 μM DpgC and 4.1 in 100 μL buffer), making NMR characterization 
of the products difficult. 
 
  We performed an NMR assay in order to gain a more detailed understanding of 
the products formed when 4.1 is incubated with the enzyme. First, an initial 1H NMR 
spectrum of the substrate derivative 4.1 was taken (t = 0). The assay was initiated with 
the addition of DpgC (10 μM) and 1H NMR spectra were acquired every 30 minutes for 8 
hours. The progression of the enzyme-catalyzed reaction is shown in Figure 4-5 and full 
NMR spectra from this assay are located at the end of the chapter. It is clear from the 
spectra that although some peaks have a change in chemical shift, the cyclopropyl 
group does not undergo any rearrangement.  In fact, it appears as though CoA is being 
hydrolyzed. The protons adjacent to the thioester (2.98 ppm) shift upfield (2.60 ppm), 
which would be expected if CoA was released. This was confirmed with reference 
spectrum of CoA in the buffered assay conditions. In addition, small changes occur in 
the chemical shifts of the cyclopropyl and aromatic protons while the splitting patterns 
remain the same. The benzylic protons of 4.1 appear to shift from 3.83 ppm to 3.46 ppm, 
which is very similar to their shift in the cyclopropyl-phenylacetic acid (4.6).  
Figure 4-4. HPLC assay of 4.1 incubated with DpgC (bottom). 
Standards of starting material and products are labeled. 
 78 
 
Figure 4-5. An NMR assay of 4.1 with DpgC. For clarity, only 3 spectra 
are shown representing the beginning, middle and the end of the assay. 
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This data, taken with the data from the HPLC assays indicate that DpgC is catalyzing the 
hydrolysis of the thioester for the deshydroxy-cyclopropyl substrate derivative.  What is 
not evident from this data is why DpgC has altered activity. DpgC has not shown strictly 
hydrolytic activity previously, despite the fact that it is entirely plausible with the 
positioning of the oxyanion hole and anchored water molecule (W258, Figure 3-1). Of 
note, DpgC was shown to oxidize phenylacetyl-CoA, although activity was reduced as 
compared to the natural substrate (Chapter 3). Perhaps the probe 4.1 is binding in an 
alternate conformation. Would a cyclopropyl derivative with one or both hydroxyls on the 
aromatic ring show wild-type activity or the altered hydrolytic activity? Experiments with 
substrates 4.2 and 4.3 are on-going in our laboratory. 
 
Cys319Ala DpgC to probe the radical mechanism 
 Another strategy we adopted to probe the radical mechanism of DpgC entailed 
making point mutations in the active site. A crystal structure was recently reported for 
PerR, an enzyme that regulates the response to hydrogen peroxide in B. subtilis18. PerR 
is a redox switch that senses H2O2 by metal-catalyzed histidine oxidation. This histidine 
oxidation was confirmed in the X-ray crystallographic structure and also by LC-MSMS 
techniques. In an analogous fashion, we chose to introduce a cysteine into the active in 
the hopes of trapping any reactive oxygen species (ROS) that is formed. This occurs in 
other bacterial redox switches, such as OxyR in E. coli19. A cysteine residue in a 
hydrophobic pocket of OxyR is oxidized by H2O2, which enables disulfide bond 
formation. We plan to characterize our system by x-ray crystallography and LC-MSMS 
analysis to determine if any ROSs are trapped by the introduced cysteine.  
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 We used the crystal structure of native DpgC to select the placement of the 
cysteine mutation in the active site. This required proximity to the binding site of O2 
without altering binding of either dioxygen or the substrate. From the hydrophobic 
binding pocket, we chose residues Val425 and Leu237.  We had already shown that 
altering the hydrophobicity of the pocket had a detrimental effect on activity (Chapter 2). 
Therefore, we also chose to make an Ala319Cys variant. Cys319 is located on the edge 
of the hydrophobic pocket at the opening of the active site (Figure 4-6). All three 
mutants were successfully prepared via site-directed mutagenesis, but only the 
Ala319Cys-DpgC construct expressed as a soluble protein. In an HPLC assay, 
Ala319Cys-DpgC appeared to have little to no activity. Kinetic parameters for DPA-CoA 
were determined with DNTB assays (KM = 125 ± 54 μM, kcat 5.7 ±0.78 min-1). The 
catalytic efficiency of Ala319Cys-DpgC was found to be 1.5% that of the wild-type.  
  
 Ala319Cys-DpgC was found to co-crystallize with the substrate DPA-CoA. This 
indicated that the substrate was binding but not turning over, at least not at an 
appreciable rate. Apo-DpgC does not crystallize under these conditions and apo-DpgC 
Figure 4-6. Molecular and surface view of the active site. Hydrophobic 
pocket residues are shown in green and residues targeted for mutation to 
cysteine are shown in orange. 
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crystals soaked with DPA-NH-CoA disintegrate upon mixing. The structure was solved to 
2.6 Å and is similar to all the previously determined structures of DpgC. The CoA portion 
of the molecule seems to have low occupancy, as density is non-contiguous.  The 
aromatic ring, however, had consistent density located in the position where it typically 
binds in the wild-type DpgC. Density for the cysteine residue is clear, and it is contiguous 
with density to the aromatic ring. Intriguingly, the density appears as though the cysteine 
residue connected to DPA through the carbonyl (Figure 4-7). The cysteine side chain by 
itself is not long enough to stretch this distance, so there must be intervening atoms. Is 
the cysteine trapping super-oxide, then cleaving the DPA-CoA thioester? Perhaps the 
proposed benzylic-peroxy intermediate is trapped by the cysteine. Or is this density the 
result of a well-ordered water molecule linking the cysteine to a hydrolyzed 
dihydroxyphenyl acetic acid? In typical assay conditions, a very limited amount of CoAS 
fomation is observed. The Ala319Cys-DpgC/DPA-CoA crystals took several days to 
grow, and while hydrolysis of the thioester has not been observed in aqueous conditions 
overnight, there is a possibility that hydrolysis occurs over the period necessary for 
Figure 4-7. Electron density for Ala319Cys-DpgC.  Density shown at 1.4 .  Two 
views are shown, one is a side view of DPA-CoA (left) and the other is top view of 
DPA-CoA (right) in the active site. 
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crystal growth. As a control, we attempted to grow crystals of Ala319Cys with DPA-NH-
CoA. While we have obtained crystals, we have yet to obtain crystals of sufficient 
diffraction quality for structural elucidation.  
 Biochemical evidence will be necessary to determine the nature of the density 
seen in these crystals. Ala319Cys-DpgC was incubated with DPA-CoA before being 
subjected to trypsin digest. In-house LCMS experiments identified some predicted 
peptide fragments (ExPASy Peptide Cutter), however, peptides containing the Cys319 
residue could not be positively identified. A similar experiment was performed and the 
samples were sent to the University of Wisconsin Biotechnology Center so that if the 
target peptide was identified, tandem MS experiments could be performed. A definitive 
assignment of the target peptide could not be made. A chromatogram with a list of the 
peptide fragments measured is shown at the end of the chapter. Differences between 
the peptides generated for Ala319Cys-DpgC and WT-DpgC were examined, but no 
concrete conclusions could be obtained from this data. It will be necessary to optimize 
the experimental methods and more experiments will have to be performed to gain 
concrete evidence. 
  
Conclusion 
 We have solved the first structure of a cofactor-free dioxygenase. The use of a 
stable substrate mimic allowed us to identify the active site and catalytically relevant 
amino acids. We were also able to identify a hydrophobic pocket with a putative 
dioxygen molecule bound. A mechanism has been proposed and we have substantiated 
the initial steps using the tools of protein x-ray crystallography, organic synthesis, and 
biochemistry. We have yet to validate mechanistic steps downstream of enolate 
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formation. Determining if DpgC does indeed catalyze an electron transfer from DPA-CoA 
to O2 is not a trivial task. While this step seems chemically viable, to date, it has not been 
confirmed experimentally for any of the cofactor free oxygenases. We have laid the 
groundwork for future studies to uncover the details of this fascinating chemistry. 
 
Materials and Methods 
Site-directed mutagenesis.  Amino acid point mutations of DpgC were made using the 
QuikChange Site-Directed Mutagenesis Kit (Stratagene: La Jolla, CA).  DpgC from the 
Streptomyces toyocaensis A47934 gene cluster cloned into the vector pET30a was used 
as the template.  PCR amplification was performed following the manufacturer’s protocol 
with the following primers and their reverse compliments (modified sequences 
underlined):  Ala319Cys, 5’-TTC AGC CTT CCC TGC GCG AAG GAG-3’; Val425Cys, 
5’-TAC GGC CAC GAC TGC ATC GAC AAG GTC-3’; Leu237Cys, 5’-GCC GGC ATC 
AAC TGC AAG TAC CTC AGC-3’.  The oligonucleotides were synthesized by Integrated 
DNA Technologies (Coralville, IA). The PCR program consisted of an initial hold of 95 oC 
for 1 min followed by 30 cycles of 95 oC for 1 min, 55 oC for 1 min, and 65 oC for 13.5 
min.  The template DNA was digested with 10U of DpnI for 1 hour at 37 oC before 
transformation into XL10-Gold Ultracompetent cells.  The mutagenesis products were 
confirmed by DNA sequencing (GENEWIZ, NJ).  
 
DpgC Mutant Expression and Purification.  BL21(DE3) E. coli cells were transformed 
with mutant vectors and grown in LB media at 37 oC until cell density reached 
OD600=0.6.  Overexpression was induced by adding IPTG (50mM), followed by overnight 
incubation at 18 oC.  Cells were pelleted using centrifugation and lysed using a French 
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Press system.  The enzymes were then purified with Ni-NTA affinity resin (Qiagen), 
dialyzed into a common buffer (20mM Tris·HCl, 50mM NaCl, pH 7.5), concentrated, 
flash frozen in buffer with 20% glycerol and stored at -80 ˚C.  
 
DpgC NMR assay. The NMR assay was performed on the Varian 500 mHz.  DpgC was 
dialyzed into a 20 mM NaHPO4 buffer (pH 7.5) in order to remove Tris buffer and 
facilitate NMR spectra interpretation.  The spectra indicate that not all of the Tris was 
removed. The NaHPO4 pH 7.5 buffer was prepared in D2O and 4-
cyclopropylphenylacetyl-CoA (4.1) was added to a concentration of 1mM.  This solution 
was placed in a Shigemi NMR tube and a 1H proton spectrum was captured.  DpgC (10 
μ) was added to the NMR tube to initiate the assay.  A 1H NMR was taken every 30 
minutes for 8 h.  A control assay was performed in which D2O was added in lieu of 
DpgC.   
 
Enzyme activity assays. Kinetic analysis for DpgC mutants was performed using the 
DTNB [5,5’-dithiobis(2-nitrobenzoic acid)] reporter assay as described20 with one 
modification: the concentration of Ala319Cys-DpgC used was 0.19 μM.  For the HPLC 
assays, DPA-CoA and 4.1 (5 mM) were each incubated with DpgC (2.5 μM) at 24 ºC 
(100 μL, 20 mM Tris·HCl pH 7.5) for 2 h. The reaction was quenched with 1 μL TFA and 
products were analyzed by analytical C18 HPLC  (1 mL/min; 0-3 min, 2% B; 3-60 min, 2-
40% B, where A=0.05% TFA/H2O and B=0.05% TFA/CH3CN), monitoring at 220 and 
260 nm.  
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Crystallization, Data Collection, and Structure Determination. Ala319Cys-DpgC (48 
kDa, 439 amino acids) was co-crystallized with DPA-CoA or DPA-NH-CoA by the 
hanging-drop method at 20 ˚C. DPA-CoA or DPA-NH-CoA (2 mM) was incubated with 
(12 mg/mL in 20 mM Tris·HCl and 50 mM NaCl, pH=7.5) at 20 ˚C for 2 hrs.  The 
Ala319Cys-DpgC/substrate complex (1.5 μL) was mixed with 1.5 μL of reservoir 
solution:  100 mM sodium citrate, 140 mM ammonium acetate, and 14% (w/v) PEG 
4000, pH 5.6.  Crystals appeared after four days at 20 ˚C.  Crystals were transferred to a 
cryoprotectant solution (reservoir solution with 20% glycerol) and soaked for 30 min 
before being flash frozen in liquid nitrogen. Diffraction data were collected to 2.6 Å at the 
X25 beamline of the National Synchrotron Light Source (NSLS) at Brookhaven National 
Labs.  Diffraction data were processed and scaled with the program package HKL2000.  
The crystal structure was solved by molecular replacement using the program CNS with 
native DpgC as the search model (PDB entry #2NP9). Refinement of the structure was 
performed with NCS restraints using program CNS.  As with the wild-type structure, only 
three of the six monomers were ordered in the crystal resulting in an Rworking= 0.35 and 
Rfree= 037. The program PyMOL (Delano Scientific, San Carlos, CA) was used to 
generate graphic images. The refinement data are shown in Table 4-1. 
 86 
 
 
        Table 4-1. Data collection and refinement statistics 
  
Data collection Ala319Cys 
Space group P21212 
Cell dimensions    
    a, b, c (Å) 141.1, 156.4, 
171.03 
    , ,   (°)  90.0, 90.0, 120.o 
Resolution (Å)  2.6 
Rsym or Rmerge 0.108 (0.622)* 
I/I  
Completeness (%) 100.0 (100.0) 
Redundancy  
  
Refinement  
Resolution (Å) 2.6 
No. reflections 115869 
Rwork/ Rfree 0.3520, 0.3763 
No. atoms  
    Protein 9520 
    Ligand/ion 172 
    Water 143 
R.m.s deviations  
    Bond lengths (Å)  1.509 
    Bond angles (º) 0.007 
  
  
  
  
          *Highest resolution shell is shown in parenthesis.  
 
 
Trypsin Digest and LCMS of Ala319Cys. Ala319Cys was expressed and purified by 
gel filtration chromatography as previously described.  It was necessary to purify the 
enzyme to homogeneity to facilitate data interpretation. Ala319Cys (2.5 μM) was 
incubated with DPA-CoA (1 mM) in common assay buffer (20 mM Tris, 50 mM NaCl, pH 
7.5) for 1 h.  A control was performed with buffer added in lieu of DPA-CoA. The enzyme 
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was then prepared according to the manufacturer’s provided instructions for the trypsin 
spin colum (Aldrich, US). Briefly, the enzyme/substrate mixture was diluted with 8M urea 
to a final enzyme concentration of 0.4 mg/mL and allowed to sit for 10 min at rt.  This 
mixture was then diluted with 100 μL of the manufacturer provided Enzyme Reaction 
Buffer and 100 μL of this solution was applied to the pre-equilibrated spin column.  The 
digest occurred for 15 min at rt.  The peptide fragments were eluted from the column 
with 150 μL of H2O, and the samples were submitted for LCMS. 
 
Synthesis of DPA-CoA Substrate Analogs. 1H NMR spectra were recorded using a 
Varian Unity 400 MHz (400 MHz) spectrometer.  Chemical shifts are reported in ppm 
from trimethylsilane with the solvent as the internal standard (CDCl3:  7.26 ppm, D2O:  
4.80 ppm).  Data are reported as follows:  chemical shift, (multiplicity [singlet (s), doublet 
(d), triplet (t), quartet (q) and multiplet (m)], integration, and coupling constants [Hz]).  
 
4-cyclopropylphenylacetic acid (4.6). Methyl 2-(4-vinylphenyl)acetate (4.5) was made as 
previously described10. In a reaction flask CH2I2 (10 eq.) was cooled to 0 °C followed by 
slow addition of diethylzinc (5 eq.) over 15 minutes. After stirring for 5 min at 0 °C, 
methyl 2-(4-vinylphenyl)acetate (4.5) in CH2Cl2 was added.  The reaction was allowed to 
warm to room temperature and continued to stir for 12 h.  Upon completion, NH4Cl was 
added and allowed to stir for several minutes. The mixture was extracted with CH2Cl2, 
washed with brine, dried over MgSO4, and concentrated in vacuo. The product was 
purified via silica gel chromatography using an isocratic 72:25 hexanes:ethyl actate 
solvent system (yield: 61%). 1H NMR:   7.14 (d, 2H), 7.01 (d, 2H), 3.65 (s, 3H), 3.56 (s, 
2H), 1.85 (m, 1H), 0.93 (m, 2H), 0.65 (m, 2H); ES+ TOF MS:190.3 (190.24 calc, 
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C11H12O2). Saponfication of the methyl ester with LiOH (5 eq.) in 3:1  MeOH:H2O, 
followed by acidic extraction with CHCl3 gave the product (4.6) in 77% yield (47% over 
two steps). 1H NMR:   7.14 (d, 2H), 7.01 (d, 2H), 3.58 (s, 2H), 1.85 (m, 1H), 0.93 (m, 
2H), 0.65 (m, 2H); ES- TOF MS:175.1 (176.21 calc, C11H12O2). 
 
4-Cyclopropylphenylacetyl-CoA (4.1). The general coupling procedure of the 
cyclopropylphenylacetic acid derivatives with coenzyme A follows published procedures 
for the synthesis of substrate DPA-CoA 1,20.  HPLC purification: (8 mL/min; 0-3 min, 2% 
B; 3-50 min 5-50% B, where A=0.1% TFA/H2O; B= CH3CN; 4-cyclopropylphenylacetyl-
CoA eluted at 37 min) 1H NMR:  8.61 (s, 1H), 8.34 (s, 1H), 7.11 (d, 2H), 6.77 (d, 2H), 
6.15 (d, 1H), 4.88 (overlapping m, 4H), 4.58 (br s, 1H), 4.25 (br s, 2H), 3.99 (s, 1H), 3.87 
(m, 1H), 3.61 (m, 1H), 3.78 (overlapping m, 4H), 3.29 (overlapping m, 4H), 2.96 (t, 2H), 
2.24 (t, 2H), 1.66 (m, 1H), 0.91 (overlapping m, 5H), 0.78 (s, 3H), 0.58 (m, 2H); ES- TOF 
MS:  958.5 (958.7 calc, C29H41N7O18P3SNa). 
 
4-Cyclopropyl-3-hydroxyphenylacetic acid. The compound 4.9 (90 mg, 0.28 mmol) was 
taken up in dry THF and transferred to a plastic bottle. TBAF (0.56 mL of 1M, 0.56 
mmol) was added and the reaction was allowed to stir at rt for 3hrs. Dilution with 1M HCl 
followed by extraction with ethyl acetate, washed with brine, dried with MgSO4, and 
concentrated in vacuo.  Next, saponfication of the 4-cyclopropyl-3-hydroxy-phenylacetic 
methyl ester with LiOH (15 mg, 0.36 mmol) in 1:1 MeOH:H2O, followed by acidic 
extraction with CH2Cl2 and concentration in vacuo to give the corresponding acid with a 
67% yield over two steps. 1H NMR:   6.75 (s, 1H, 8), 6.70 (d, 1H, 2), 6.65 (dd, 1H, 8, 2) 
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3.46 (s, 2H), 2.04 (m, 1H), 0.86 (m, 2H), 0.59 (m, 2H); ES- TOF MS: 191.1 (191.2 calc, 
C11H11O3
-).  
 
4-cylopropyl-3-Hydroxyphenylacetyl-CoA 4.2. The general coupling procedure of the 
cyclopropylphenylacetic acid derivatives with coenzyme A follows published procedures 
for the synthesis of substrate DPA-CoA 1,20. HPLC purification (8 mL/min; 0-3 min, 2% B; 
3-40 min 2-40% B, where A=0.1% H2O; B= CH3CN; 4.2 eluted 34 min. 22% yield.
1H 
NMR:   8.64 (s, 1H), 8.40 (s, 1H), 6.82 (d, 1H, 8), 6.72 (d, 1H, 2), 6.72 (d, 1H, 8, J4-2), 
6.19 (d, 1H, 6), 4.91 (overlapping m, 4H), 4.62 (br s, 1H), 4.32 (br s, 2H), 4.03 (s, 1H), 
3.92 (m, 1H), 3.79 (s, 1H), 3.66 (m, 1H), 3.34 (overlapping m, 4H), 3.01 (t,  2H, 5.7), 
2.28 (t, 2H, 6.5), 1.87 (m, 1H), 0.96 (s, 3H), 0.82 (s, 3H), 0.91 (m, 2H), 0.57 (m, 2H); 
MALDI+ TOF MS: 942.17 [M+H]  (941.70 calc, C32H42N7O18P3S
4-). 
 
4-cyclopropyl-3,5-dihydroxyphenyacetic acid. Deprotection began with saponfication of 
the methyl ester 4.12 (200 mg, 0.4 mmol) with LiOH (34 mg, 0.8 mmol) in 1:1 
MeOH:H2O, followed by acidic extraction with CHCl3 and concentration in vacuo to give 
the corresponding acid.  The acid was taken up in dry THF and transferred to a plastic 
bottle. Next, TBAF ( 400 μL, 0.4 mmol) was added and the reaction was allowed to stir at 
rt for 3hrs. Dilution with 1 M HCl followed by extraction with Ethyl acetate, washed with 
brine, dried with MgSO4, and concentrated in vacuo. HPLC purification: 8 mL/min; 0-3 
min, 20% B; 3-40 min 20-80% B, where A=0.1% H2O; B= CH3CN; 4-cyclopropyl-3,5-
dihydroxyphenylacetic acid eluted at 28 min. 46% yield over two steps. 1H NMR:   6.92 
(s, 2H), 3.82 (s, 2H), 1.85 (m, 1H), 1.02 (m, 2H), 0.81 (m, 2H); ES- TOF MS: 207.2 
(208.21 calc, C11H12O4).  
 90 
References 
 
1.  Tseng, C. C. et al. Dpgc is a metal- and cofactor-free 3,5-dihydroxyphenylacetyl-
coa 1,2-dioxygenase in the vancomycin biosynthetic pathway. Chem & Biol 11, 
1195-1203, (2004). 
2.  Frerichs-Deeken, U. et al. Dioxygenases without requirement for cofactors and 
their chemical model reaction: Compulsory order ternary complex mechanism of 
1h-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase involving general base catalysis 
by histidine 251 and single-electron oxidation of the substrate dianion†. Biochem 
43, 14485-14499, (2004). 
3.  Martin-Esker, A. A. et al. Picosecond radical kinetics. Fast ring openings of 
constrained, aryl-substituted cyclopropylcarbinyl radicals. J Am Chem Soc 116, 
9174-9181, (2002). 
4.  Griller, D. & Ingold, K. U. Free-radical clocks. Acc Chem Res 13, 317-323, 
(1980). 
5.  Newcomb, M. Competition methods and scales for alkyl radical reaction kinetics. 
Tetrahedron 49, 1151-1176, (1993). 
6.  Silverman, R. B. The organic chemistry of enzyme-catalyzed reactions.  (2002). 
7.  Newcomb, M. & Toy, P. H. Hypersensitive radical probes and the mechanisms of 
cytochrome p450-catalyzed hydroxylation reactions. Acc Chem Res 33, 449-455, 
(2000). 
8.  Valentine, A. M. et al. Oxidation of ultrafast radical clock substrate probes by the 
soluble methane monooxygenase from methylococcus capsulatus (bath). J Biol 
Chem 274, 10771-10776, (1999). 
9.  Liu, K. E. et al. Radical clock substrate probes and kinetic isotope effect studies 
of the hydroxylation of hydrocarbons by methane monooxygenase. J Am Chem 
Soc 115, 939-947, (2002). 
10.  Wright, S. W. & McClure, S. D. A convenient preparation of 4-vinylphenylacetic 
acid and its methyl ester. Org Prep Proc Intl 26, 602-604, (1994). 
11.  Deak, H. L. et al. New approach to bicyclo [5.3.0] ring systems. J Am Chem Soc 
123, 5152-5153, (2001). 
12.  Epple, R. et al. Compounds and compositions as ppar modulators. (2007). 
13.  Doucet, H. Suzuki-miyaura cross-coupling reactions of alkylboronic acid 
derivatives or alkyltrifluoroborates with aryl, alkenyl or alkyl halides and triflates. 
Eur J Org Chem, 2013-2030, (2008). 
14.  Wallace, D. J. & Chen, C.-y. Cyclopropylboronic acid: Synthesis and suzuki 
cross-coupling reactions. Tetrahdron Lett 43, 6987-6990, (2002). 
15.  Zhou, S.-M. et al. Efficient suzuki-type cross-coupling of enantiomerically pur 
cyclopropylboronic acids. Angew Chem Int Edn Engl 37, (1998). 
16.  Olah, G. A. et al. Synthetic methods and reactions. Transformations with 
chlorotrimethylsilane/sodium iodide, a convenient in situ iodotrimethylsilane 
reagent. J Org Chem 44, 1247-1251, (1979). 
17.  Zuo, L. et al. An efficient method for demethylation of aryl methyl ethers. 
Tetrahdron Lett 49, 4054-4056, (2008). 
18.  Traore, D. A. K. et al. Structural and functional characterization of 2-oxo-histidine 
in oxidized perr protein. Nat Chem Biol 5, 53-59, (2009). 
 91 
19.  Choi, H.-J. et al. Structural basis of the redox switch in the oxyr transcription 
factor. Cell 105, 103-113, (2001). 
20.  Widboom, P. F. et al. Structural basis for cofactor-independent dioxygenation in 
vancomycin biosynthesis. Nature 447, 342-345, (2007). 
 
 
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
O
2 H
4.6
 93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
S
C
oA
4.1
 94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
H
O
H O
 95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
H
S
-C
oA
O
4.2
 96 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
O
T
B
S
T
B
S
O
O
M
e O
4.12
 97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
o
n
tro
l fo
r N
M
R
 a
s
s
a
y
.  4
-c
y
c
lo
p
ro
p
y
l-p
h
e
n
y
la
c
e
ty
l-C
o
A
 
in
 b
u
ffe
r. 1H
 N
M
R
 s
p
e
c
tru
m
 a
q
u
ire
d
 e
v
e
ry
 3
0
 m
in
u
te
s
 fo
r 
4
 h
o
u
rs
 (s
ta
rtin
g
 a
t b
o
tto
m
) 
 
 98 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NMR assay.  4-cyclopropyl-phenylacetyl-CoA  incubated with DpgC in buffer. 1H NMR 
spectrum aquired every 30 minutes for 8 hours (1 hr increments shown,starting at 
bottom). 
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Total ion chromatogram of Ala319Cys trypsin digest.  The chromatagrams for the enzyme 
incubated with DPA-CoA (red) and the control are shown (black).  A list of all the fragments found 
below. 
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Chapter 5: Efforts toward structural  characterization of 
SgcC5, a stand-alone nonribosomal peptide synthetase 
condensation domain. 
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Introduction 
 The enediynes are a class of natural products that exhibit potent cytotoxicity 
towards tumor cells, which has made them attractive leads for the development of 
therapeutics1,2. C-1027 (Figure 5-1), a member of the enediyne family, is an antibiotic 
produced by the soil microbe Streptomyces globisporus. The biological activity and 
structural complexity of C-1027 has inspired the pursuit of its total synthesis3. As 
synthetic routes are often expensive, time consuming, and provide low overall yields, 
their use in the development of natural product based therapeutics is impractical. In fact, 
most antibiotics produced today are still produced commercially by the optimized 
fermentation of a producing organism4. More recently, genetic engineering of a 
biosynthetic pathway in Saccharomyces cerevisiae led to high titres in the production of 
artemisinic acid5, the direct precursosr to artemisinin6. 
 Bacteria use enzymatic machinery to synthesize natural products. These 
biosynthetic pathways present a viable route to generate not only natural products, but 
various analogs as well7,8. This can be accomplished with tools of genetic engineering 
and combinatorial biosynthesis. However, development of these methods in a rational 
manner requires a detailed understanding of how these biosynthetic enzymes function. 
As these enzymes work in tandem like an assembly line, it is important to understand 
not only substrate scope, but the recognition events that occur between the enzymes 
themselves.  Tailoring enzymes are attractive targets as they catalyze the final chemical 
steps of a biosynthetic pathway and introduce various functionality (i.e. via oxidation, 
glycoslyation, prenylation)9. Manipulation of a biosynthesis at the end of the pathway 
would get around difficulties that may occur with changes at the beginning of a 
synthesis, which would have to be tolerated through the entire pathway. 
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 The four main components of C-1027, an aminosugar, a benzoxazolinate, a      
-tyrosine, and the enediyne core, are all separately biosynthesized, then assembled via 
tailoring enzymes to form the mature natural product (Figure 5-1)10. These enzymes 
have the potential to be developed as chemoenzymatic catalysts, coupling different 
moieties to the core3 and thus making analogs of C-1027. To logically exploit these 
tailoring enzymes, we must understand the mechanistic details of the chemistry they 
perform. To this end, we set out to determine the crystal structure of SgcC5, the tailoring 
enzyme that couples the -tyrosine moiety to the enediyne core.  Any insight gained will 
allow us to design alternate substrates that could be coupled to the core, providing a 
pathway to the production of C-1027 analogs. 
  SgcC5 is a free-standing condensation enzyme that displays interesting activity 
as it catalyzes ester bond formation11, as opposed to the canonical amide bond of other 
NRPS condensation domains12. In addition, a second coupling occurs forming an ether 
linkage from the -tyrosine to the enediyne core (Figure 5-2), but it is unclear if SgcC5 
Figure 5-1. Convergent biosynthesis of C-1027 by the 
three tailoring enzymes SgcC5, SgcD6, and SgcA6. 
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catalyzes this bond formation. In fact, to date, there is limited biochemical 
characterization of this enzyme. Lin et al. have demonstrated that SgcC5 does catalyze 
ester bond formation between its -tyrosine substrate and an enediyne core mimic.
 While the exact enediyne core substrate of SgcC5 is unkown, a phenylethane 
diol mimic was used for characterization (Figure 5-2). Catalytic amide-bond formation 
was also demonstrated for this enzyme, albeit with ~4000-fold less efficiency. A structure 
of SgcC5 would help in understanding this selectivity. Perhaps the size and structure of 
SgcC5’s active site will provide insight into the substrate this enzyme recognizes. Since 
the enzyme can recognize the phenyl-ethanediol core mimic used, does that mean that 
coupling of the benzoxaolinate occurs later? The viability of phenylethane diol as a 
substrate suggests that the enzyme is either promiscuous or the core may be cyclized 
by the time it reaches SgcC5. Is the enzyme itself catalyzing a tandem coupling reaction 
with formation of the ether bond? And finally, are there features in the structure that 
could be exploited for future engineering purposes? 
 
 
Figure 5-2. (A) Reaction catalyzed by SgcC5. (B) The enediyne 
core mimic used for biochemical assays and co-crystallization. 
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Crystallization of SgcC5 
  The enzyme SgcC5 was expressed and purified to homogeneity with relative 
ease (Figure 5-3), but growing crystals of SgcC5 proved more difficult. The enzyme was 
screened for crystallization conditions using commercially available screens at 4 and 20 
°C (Hampton, Wizard, MDL, Qiagen). When initial attempts at these screens gave no 
reproducible hits, the protein concentration 
was varied with similar results. Purified 
protein was also sent to the Hauptman-
Woodward Institute (Buffalo, NY) for an 
additional 1536 conditions. No tangible 
leads were obtained from these screens. 
 A stand-alone condensation domain from the vibriobactin biosynthetic pathway, 
VibH, has been structurally characterized13. A sequence alignment of SgcC5 and  VibH 
performed with ClustalW14 revealed that SgcC5 had a non-homologous N-term (Figure 
5-4). This region could be acting as a ‘floppy end’, the disorder of which may hinder 
crystallization. Therefore, a truncated construct was cloned and subsequently expressed 
and purified. This truncated 
SgcC5 was also submitted to 
high-throughput screening to 
generate crystal growth 
conditions. No reproducible hits 
were obtained. Circular 
dichroism was employed to 
ensure that the removal of the 
83 kDa 
62 kDa 
cleaved 
47 kDa 
uncleaved 
Figure 5-3. SDS-PAGE of purified SgcC5. 
Figure 5-5. Circular dichrosim spectra indicating that 
the truncated version of SgcC5 folds correctly in 
comparison to the wild-type enzyme. 
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11 amino acids was not altering the protein folding. As indicated in Figure 5-5, the 
truncated SgcC5 was folded in a similar fashion to the wild-type.  
  
In addition to examining a truncated construct, we investigated the effects of surface 
modification to aid in crystallization15,16. This involved reductive methylation of lysine 
residues, which has been shown to facilitate crystal formation17. Native and truncated 
SgcC5 were subjected to reductive methylation. This process was monitored by a 
colorimetric assay and formaldehyde consumption, and all protein modifications were 
SgcC5      MTTSDTTDRSQDGVPPLSFHQEFLCMFDSGNDGADVGPFGPMYHIVGAWRLTGGIDEETL  
VibH       -----------MLLAQKPFWQRHLAYPHIN-----------LDTVAHSLRLTGPLDTTLL  
                        :.  .* *..*.  . .           :  :. : **** :*   * 
 
SgcC5      REALGDVVVRHEALRTSLVREGGTHRPEILPAGPAALEVRDLGDVDESERVRRGEELLNE  
VibH       LRALHLTVSEIDLFRARFSAQGELYWHPFSPP----IDYQDLSIHLEAEPLAWRQIEQDL  
            .**  .* . : :*: :  :*  :   : *.    :: :**.   *:* :   :   :  
 
SgcC5      VESTGLSVRELPLLRAVLGRFDQKDAVLVLIAHHTAADAWAMHVIARDLLNLYAARRGNP  
VibH       QRSS--TLIDAPITSHQVYRLSHSEHLIYTRAHHIVLDGYGMMLFEQRLSQHYQSLLSG-  
            .*:  :: : *:    : *:.:.: ::   *** . *.:.* :: : * : * :  ..  
 
SgcC5      VPPLPEPAQHAEFARWEREAAEAPRVAVSKEFWRKRLQGARIIGLETDIPRSAGLPKGTA  
VibH       QTPTAAFKPYQSYLEEEAAYLTSHRYWQDKQFWQGYLREAPDLTLTSAT-YDPQLSHAVS  
            .* .    : .: . *     : *   .*:**:  *: *  : * :    .. *.:..: 
 
SgcC5      WQRFAVRGELADAVVEFSRAAKCSPFMTMFAAYQVLLHRRTGELDITVPTFSGGRNNSRF  
VibH       LS-YTLNSQLNHLLLKLANANQIGWPDALVALCALYLESAEPDAPWLWLPFMN-RWGSVA  
            . :::..:* . :::::.* : .   ::.*   : *.    :      .* . * .*   
 
SgcC5      EDTVGSFINFLPLRTDLSGCASFREVVLRTRTTCGEAFTHELPFSRLIPEVPELMASAAS  
VibH       ANVPGLMVNSLPLLRLSAQQTSLGNYLKQSGQAIRSLYLHGR---YRIEQIEQDQGLNAE  
            :. * ::* ***    :  :*: : : ::  :  . : *       * :: :  .  *. 
 
SgcC5      DNHQISVFQAVHAPASEGPEQAGDLTYSKIWERQLSQAEGSDIPDGVLWSIHIDPSGSMA  
VibH       QSYFMSPFINILP--FESPHFADCQTELKVLASGSAEGINFTFRGSPQHELCLDITADLA  
    :.: :* *  : .   *.*. *.  *  *:     ::. .  : ..   .: :* :..:* 
 
SgcC5      GSLGYNTN-------RFKDETMAAFLADYLDVLENAVARPDAPFTS-------  
VibH       SYPQSHWQSHCERFPRFFEQLLARFQQVEQDVARLLAEPAALAATTSTRAIAS  
                .    : :       ** :: :* *     ** .  .  .  . *:        
 
Figure 5-4. Clustal W strucutural alignment of SgcC5 with the vibriobactin condensation domain, 
VibH.  The conserved condensation domain motif is underlined. Symbols: (*)- identical residue, (:) 
- conserved residue substitution, (.) – semi-conserved residue substitution. 
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confirmed by mass spec analysis. The methylated protein was put through the same 
high-throughput screens, but still no protein crystals were obtained.  
 SgcC5 has to recognize -tyrosine attached to a peptidyl carrier protein (SgcC2) 
as well as the enediyne core. It is not known what type of dynamics are involved in 
SgcC5 binding these substrates. It is entirely possible that the enzyme is too mobile for 
crystallization unless a substrate is present to ‘lock’ it into place. We have already seen 
this with disordered loops around the active site in the apo-structure of DpgC. We 
thought crystal formation could be promoted by co-crystallization of the enzyme with a 
stable substrate mimic.  
 
Synthesis of stable SgcC5 substrate mimics 
 A synthesis of the 3-chloro-5-hydroxy--tyrosine moiety of C-1027 was reported 
in 199918.  We attempted to use this precedent to synthesize the -tyrosine and couple it 
to N-Acetylethylenediamine (NNAC) to make a stable substrate mimic (Figure 5.6). 
Previous work with NRPS condensation domains demonstrated that the enzymes will 
accept the aminoacyl-N-acetylcysteamine thioesters (aminoacyl-SNACs) as 
substrates19.  In an analogous fashion to the work 
performed with DpgC and amino-CoA substrate 
derivatives, the -tyrosine-NNAC should provide a 
non-hydroylable substrate that will bind in the active 
site.  Since SgcC5 had proven recalcitrant to 
crystallization, we hoped that a bound substrate mimic 
would help to rigidify the enzyme and facilitate crystal 
growth.  
Figure 5-6. A stable substrate 
mimic for SgcC5, 3-chloro-5-
hydroxy--tyrosine-NNAC. 
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O
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Our initial synthesis followed the precedent closely, with the only difference occurring in 
the protection group used on the 5-OH of the -tyrosine (Scheme 5-1). Protection of the 
alcohols of 3-chloro-4,5-dihydroxy-benzaldehyde as TBS ethers gave 5.3, which was 
subjected to a Horner-Wadsworth-Emmons olefination 5.420.  Next, conjugate addition of 
Davies’ chiral lithium amide afforded the fully protected (S)--tyrosine 5.5. In the 
literature precedent, problems arose with removal of the aromatic groups from the chiral 
auxiliary. The protecting groups had to be adjusted. Similarly for us, the synthesis 
proceeded smoothly until this step. The reported hydrogenolysis with Rh/C failed in our 
hands under many different conditions. We screened different catalysts (Pd/C, 
Pd(OH)2/C), pressures, solvents, and concentrations with no observation of the desired 
product.   
 
After numerous attempts, we re-evaluated our synthesis and changed to a route that 
was showing promise in a related project21.  This new synthetic route is outlined in 
Scheme 5-2. 
Scheme 5-1. (a) BBr3, CH2Cl2, 95% (b) TBDMSCl, Et3N, 
DMAP, DCM, 99% (c) NaH, (EtO)2P(O)CH2CO2tBu, THF, 
80% (d) nBuLi, (R)-(-methylbenzyl)benzylamine, 84% 
Cl
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H O
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 The new route begins with the same preparation of 5.3. Next, Ellman’s N-tert-
butylsulfinimine was used to prepare imine 5.7, which could be subjected to a 
Reformatsky addition to yield the fully protected (S)--tyrosine derivative.  Both the N-
sulfinyl and the TBS groups can were removed under acidic condtions to afford 3-chloro-
5-hydroxy-(S)--tyrosine. Boc protection of the amine and coupling to N-
acetylethylenediamine (NNAC) followed by Boc removal gave 5.1. 
  
 With the substrate analog in hand, we screened for co-crystallization conditions 
using the same high-throughput techniques. SgcC5 was incubated with either 5.1, or 5.1 
and the phenylethane diol core mimic used in biochemical studies. An amino-
pantetheine phosphate derivative of the -tyrosine substrate was also made. 
Scheme 5-2. (a) BBr3, CH2Cl2, 95%; (b) TBDMSCl, 
TEA, DMAP, 96%; (c) N-propanesulfinamide,CsCO3, 
DCM , 72%; (d) Zn, BrCH2CO2Et, THF, 64%; (e) 6 N 
HCl, propylene oxide, 64% (f) Boc2O, NaOH, 
H2O:dioxane, 25%; (g) NNAC, PyBOP, DIPEA, DMF 
(h) 1:1 TFA:H2O, 25% (two steps) 
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Unfortunately, the co-crystallization attempts did not facilitate growth of reproducible, 
diffraction quality crystals. 
 The major bottleneck in macromolecular x-ray crystallographic structural studies 
is obtaining high-quality crystals.  SgcC5 is a prime example of a protein that, while 
readily producible in large, pure quantities, is recalcitrant to crystallization.  
  
 
Materials and Methods 
SgcC5 cloning and purification. An E. coli expression plasmid (pET30 LIC) containing 
the gene for SgcC5 with an N-terminal hexa-histidine (His) tag was obtained from Dr. 
Ben Shen (UW Madison). The SgcC5 plasmid was transformed into BL21(DE3) cells 
and grown in LB media at 37 oC until cell density reached O.D600.=0.6.  Overexpression 
was induced by adding 50 mM IPTG, followed by overnight incubation at 18 oC.  Cells 
were pelleted and lysed using a French Press system. The enzyme was then purified 
with Ni-NTA affinity resin (Qiagen), followed by cleavage of the hexa-histidine tag with 
the protease Factor Xa (24 hr at 4  oC).  Further purification was performed with a HiTrap 
Q ion exchange column followed by a HiLoad 16/60 SuperDex 200 gel filtration column 
(GE Biosciences).  
 
Truncated SgcC5 construct. The truncated gene was amplified from the SgcC5 
expression plasmid using the following primers: C-term 5’- GCG GGA TCC TCA GGA 
GGT GAA GGG GGC CTC C-3’, N-term 5’-GCG CAT ATG GAC GGC GTG CCG CCG 
CTC-3’ with BamH1 and NdeI restriction sites (underlined) included. This gene was 
ligated into vector pET-16b. The truncated SgcC5 gene product was confirmed by DNA 
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sequencing (GENEWIZ: North Brunswick, NJ). Protein expression and purification was 
the same as described for native SgcC5. An Aviv circular dichroism spectrometer model 
202 was used to obtain CD spectra from 195 to 300 nm. All experiments were carried 
out using 2 ml of 10 μg/mL purified SgcC5 and SgcC5t in 50 mM NaH2PO4 buffer (pH 
7.0).  
 
Reductive Methylation of SgcC5. The reductive methylation of the lysine residues of 
SgcC5 was adapted from a published procedure22. To 250 μL of purified SgcC5 (7.4 
mg/mL; 50 mM HEPES, 100 mM NaCl, pH 7.5) was added 5 μL of dimethylamine-
borane complex (ABC) and the solution was gently mixed. Immediately, 10 μL of freshly 
made 1M formaldehyde was added and the solution was mixed before it was allowed to 
sit for 2 hr at 4 °C.  The ABC – formaldehyde addition steps were repeated and after 2 
hr, 2.5 μL of additional 1M ABC was added and the reaction mixture was left overnight at  
4 °C.  The reaction was quenched with 20 μL of 1M ammonium sulfate.  The protein 
mixture was then dialyzed (50 mM HEPES, 50 mM NaCl, 1 mM DTT, pH 7.5) before 
size-exclusion chromatography. An aliquot of the purified, modified protein was sent to 
UIUC for MALDI mass analysis ( control: 50487.18 modified protein: 50681.2). The mass 
difference of 194 corresponds to modification of single methylation of 13 lysine residues 
(or double of 6.5). SgcC5 has 6 lysine residues. 
 The course of the reaction was monitored via a colorimetric assay to determine 
the amount of free amine and by determination formaldehyde consumption.  A 25 μL 
aliquot of the protein methylation reaction was mixed with 25 μL of assay solution (100 
mM Na2B4O710 H2O, 40 mM KIO3, 40 mM KI, pH 8.5) and incubated for 15 min at 37 
°C.  Next 450 μL of 1% trinitrobenzene sulfonate (TNBS) was added and the mixture 
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was incubated for 30 min at 37 °C. The assay reaction was quenched via addition of 0.5 
mL 10% sodium dodecyl sulfate (SDS) and 0.5 mL 0.5M HCl.  The absorbance was 
measured at 420 nm using the extinction coefficient 1.4 x 104 M-1 cm-1. For monitoring 
formaldehyde consumption, 20 μL of the protein methylation reaction was added to 5 mL 
of assay solution (15 g ammonium acetate, 0.3 mL acetic acid, 0.2 mL 2,4-
pentanedione, 50 mL MeOH in 100 mL dd H2O) and incubated at 37 °C for 1 hr. The 
absorbance of the solution was measured at 412 nm and the extinction coefficient of 1.8 
x 104 M-1 cm-1 was used to determine concentration.  
 
Crystallizaiton of SgcC5.   Purified SgcC5 and truncated SgcC5 was concentrated to 
10 and 15 mg/mL solutions for use in the high-throughput crystallographic screens 
(Hampton, MDL, Wizard, Qiagen). Using sitting-drop, 96-well plates, 1.5 μL of the 
protein was mixed with 1.5 μL of the crystallographic screen conditions. The screens 
were set up at 4 and 20 °C. The screens were examined weekly for a couple of months 
for signs of crystal formation.  For co-crytallographic studies, SgcC5 was first incubated 
with 2 mM 5.1 and (R)-phenyl-1,2 ethane diol for 1 hour before being subjected to 
screening.  Protein was prepared in a similar fashion and shipped to the Hauptman-
Woodward Institute (Buffalo, New York) for further screening via robotic methods. 
 
Synthesis of (S)--Tyrosine Substrate Analogs. 1H NMR spectra were recorded using 
a Varian Unity 400 MHz or Varian INOVA 500 MHz spectrometer. Chemical shifts are 
reported in ppm from trimethylsilane with the solvent as the internal standard (CDCl3:  
7.26 ppm, D2O:  4.80 ppm).  Data are reported as follows:  chemical shift, (multiplicity 
[singlet (s), doublet (d), triplet (t), quartet (q) and multiplet (m)], integration, and coupling 
 114 
constants [Hz]. HPLC purifications performed on a Shimadzu LC-6AD LC system with a 
VYDAC C18 column. 
 
3-chloro-3,5-dihydroxy-(S)--tyrosine. The fully protected -tyrosine 5.8 (0.24 g, 0.4 
mmol) was placed in a flask with 6N HCl (3.0 mL) and refluxed at 110 °C for 2.5 hr 
before the reaction was cooled and concentrated. The oil was taken up isopropanol (2.5 
mL) and propylene oxide (85.9 μL) and stirred for 2 h at rt.  The reaction was filtered and 
the filtrate was concentrated and purified via HPLC to give 3-chloro-3,5-dihydroxy-(S)--
tyrosine in a 64% yield. HPLC: 8 mL/min; 0-3 min, 2% B; 3-35 min 2 - 60% B, where A = 
O.1% TFA/H2O, B = MeOH; 3-chloro-5-hydroxy-tyrosine eluted at 35 min  7.03 (s, 
1H), 6.91 (s, 1H), 4.63 (t, 1H, J=7.2), 3.01 (overlapping dd, 2H)  ESI- TOF: 230.6 (231.6 
calc, C9H10ClNO4)  
 
3-((tert-butoxycarbonyl)amino)-3-(3-chloro-4,5-dihydroxyphenyl)propanoic acid 5.9. To 
an eppendorf tube containing 3-chloro-5-hydroxy-(S)--tyrosine (12.3 mg, 0.057 mmol) 
in 1:1 dioxane:H2O (300 μL) was added freshly distilled Boc2O (26 μL, 0.11 mmol) and 
NaOH (2.5mg, 0.063 mmol). The reaction was shaken for 1 hr then concentrated. HPLC 
purification: 8 mL/min; 0-3 min, 2% B; 3-45 min 2- 30% B, where A = O.1% TFA/H2O, B 
= CH3CN; Boc-protected 3-chloro--tyrosine eluted at 54 min with a 30% yield.  6.75 (s, 
1H), 6.69 (s, 1H), 3.22 (t, 1H), 2.65 (m, 2H), 1.40 (s, 9H); ES- TOF MS: 330.06 (330.7 
calc, C15H20ClNO6).   
 
3-Choro--tyrosine-aminopantetheine phosphate. Boc-protected 3-chloro--tyrosine (2.5 
mg, 0.0075 mmol) was put in an eppendorf tube with PyBOP (7.8 mg, 0.015 mmol), 
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K2CO3 (4.2 mg, 0.03 mmol), aminopantetheine phosphate (2.8 mg, 0.005 mmol), and 1:1 
THF:H2O (500 μL).  The tube was shaken for 2 hrs at room temperature before addition 
of 1 μL of TFA. The reaction was lyophilized and the crude material was purified via 
HPLC: 8 mL/min; 0-3 min, 2% B; 3-60 min 2- 40% B, where A = O.1% TFA/H2O, B = 
CH3CN; Boc-protected 3-chloro--tyrosine-aminopantetheine phosphate eluted at 45 min 
with a 30% yield.  7.34 (s, 1H), 7.13 (d, 1H, 8), 6.99 (d, 1H, 8), 4.02 (s, 1H), 3.77 (m, 
2H), 3.55 (m, 2H), 3.45 (m, 2H), 3.16 (overlapping m, 4H), 2.65 (m, 4H), 2.41 (t, 2H), 
1.36 (s, 9H), 0.95 (s, 3H), 0.87 (s, 3H). ES- TOF MS: (653.02 calc, C25H38ClN4O12P
-). 
ENFIII094 The boc-protected (S)--tyrosine-aminopantetheine phosphate was taken up 
in 50:50 TFA:H2O and stirred at rt for 45 min before being concentrated and purified. 
HPLC purification: 8 mL/min; 0-3 min, 2% B; 3-60 min 2- 40% B, where A = O.1% 
TFA/H2O, B = CH3CN; 3-chloro--tyrosine-aminopantetheine phosphate eluted at 22.5 
min with a 20% yield.  7.48 (s, 1H), 7.26 (d, 1H, 8.7), 7.08 (d, 1H, 8.7), 4.06 (s, 1H), 
3.77 (m, 2H), 3.51 (m, 2H), 3.45 (overlapping m, 2H), 3.16 (overlapping m, 4H), 2.65 (m, 
4H), 2.38 (t, 2H), 0.96 (s, 3H), 0.87 (s, 3H). ES- TOF MS: (552.9 calc, C20H30ClN4O10P
-). 
 
(S)-N-(2-acetamidoethyl)-3-amino-3-(3-chloro-4,5-dihydroxyphenyl)propanamide ((S)- 
S-3-chloro-5-hydroxy--tyrosine-NNAC) 5.1. The -tyrosine-N-sulfinimide (10 mg, 0.03 
mmol) was shaken in an eppendorf tube with PyBOP (23 mg, 0.04 mmol), DIPEA (20 
μL, 0.12 mmol), and N-Acetylethylenediamine (6 μL, 0.06 mmol) in DMF (1 mL) for 2 h.  
The reaction was quenched with 1 μL of TFA, concentrated and purified. HPLC 
purification: 8 mL/min; 0-3 min, 2% B; 3-60 min 2- 50% B, where A = O.1% TFA/H2O, B 
= CH3CN; 3-chloro--tyrosine-NNAc-sulfinamide eluted at 35 min.  6.97 (s, 1H), 6.84 (s, 
1H), 4.59 (t, 1H), 3.13 (overlapping m, 2H), 3.07(overlapping m, 4H), 2.81 (m, 2H), 1.89 
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(s, 3H), 1.24 (overlapping m, 9H) The fractions at 35 min were pooled and concentrated.  
Incubation in 1:1 TFA:H2O for 1 h led to the desired NNAC product. HPLC purification: 8 
mL/min; 0-3 min, 2% B; 3-60 min 2- 50% B, where A = O.1% TFA/H2O, B = CH3CN; (S)-
3-chloro--tyrosine-NNAC eluted at 17 min with a 5% yield over both steps.  7.48 (s, 
1H), 7.26 (d, 1H, 8.7), 7.08 (d, 1H, 8.7), 4.06 (s, 1H), 3.77 (m, 2H), 3.51 (m, 2H), 3.45 
(overlapping m, 2H), 3.16 (overlapping m, 4H), 2.65 (m, 4H), 2.38 (t, 2H), 0.96 (s, 3H), 
0.87 (s, 3H). ES- TOF MS: 314.0 (315.1 calc, C13H18ClN3O4). 
 
3-chloro-4,5-dihydroxybenzaldhyde 5.2. 3-chloro-4-hydroxy-5-methoxybenzaldhyde (2 g, 
10.7 mmol) was placed into a dry, N2 flushed round bottom flask equipped with a 
magnetic stir bar and a septum with 20 mL dry DCM.  The mixture was cooled to 0 °C 
before slow addition of BBr3 (12 mL, 12.0 mmol).  The reaction was allowed to warm to rt 
with stirring for 16 h.  The reaction was diluted with 20 mL of MeOH and concentrated in 
vacuo. This MeOH wash was repeated 2 times, then the product was taken up in DCM 
and filtered to give a blue solid (95% yield) which was stored at 0 °C in a foil-wrapped 
container. ESI+ TOF: 173.0 (172.5 calc, C7H5O3Cl)  
 
3,4-Bis(tert-butyldimethylsilyoxy)-5-chlorobenzaldhyde 5.3. To a dry, N2 flushed round 
bottom flask was added 5.2 (1.9 g, 11.4 mmol) and DMAP (0.4 g, 3.2 mmol) in 20 mL of 
dry DCM, which was cooled to 0 °C.  TBDMSCl (1 g, 70 mmol in 5 mL DCM) and freshly 
distilled TEA (11 mL, 40 mmol) were added slowly.  The reaction was allowed to warm to 
rt with stirring over 16 h.  After dilution with NH4Cl, the mixture was extracted with ether, 
dried with MgSO4, and concentrated in vacuo to give a brown oil.  Purification via silica 
gel column chromatography (hexanes:diethyl ether 90:10) gave the product 5.3 in 96% 
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yield. 1H NMR:  9.75 (s, 1H), 7.52 (s, 1H), 7.28 (s, 1H), 1.02 (s, 9H), 0.95 (s, 1H), 0.23 
(s, 6H), 0.20 (s, 6H). ES+ TOF: 402.1 (401.09 calc, C19H33ClO3Si2). 
 
(R,E)-N-(3,4-bis(tert-butyldimethylsilyloxy)-5-chlorobenzylidene)-2-methylpropane-2-
sulfinamide 5.7. Benzaldehyde 5.3 (560 mg, 1.4 mmol) was dissolved in 30 mL of DCM 
in a dry, N2 flushed, flask.  CsCO3 (500 mg, 1,5 mmol) and N-propanesulfinamide (170 
mg, 1.4 mmol) were added to the flask. The reaction was refluxed at 40 °C for 12 h. After 
the reaction cooled, the solution was filtered through celite and washed with DCM. The 
filtrate was pooled, concentrated, and purified via silica column chromatography 
(hexanes: ethyl acetate 95:5) to give 5.7 as a colorless oil. 72% 1H NMR:  8.39 (s, 1H), 
7.46 (d, 1H, 2), 7.27 (buried d, 1H), 1.25 (s, 9H), 1.041 (s, 9H), 0.974 (s, 9H), 0.25 (d, 
6H, 5.6), 0.22 (s, 6 H). ES+ TOF: 504.21 (504.27 calc, C23H42ClNO3SSi2). 
 
(S)-ethyl-3-(3,4-bis(tert-butyldimethylsilyloxy)-5-chlorophenyl)-3-((R)-1,1-
dimethylsulfinamido)propanoate. 5.8. For the Reformansky reaction the zinc was first 
prepared by mixing zinc powder (200 mg) with 20 mL 5% HCl for 30 min.  The zinc was 
filtered and washed with water, actone, and diethyl ether before it was dried.  The dry 
zinc (0.12 g) was taken up with dry THF (10 mL) and transferred to a flask charged with 
dry THF (20 mL) and 5.7 (0.5 g), The reaction stirred at rt for 16 h.  The reaction was 
filtered through celite and washed with THF. The mixture was concentrated and purified 
via silica column chromatography to yield 5.8 as a yellow oil. 64%  1H NMR:  6.97 (s, 
1H), 6.83 (s, 1H), 4.50 (dd, 1H), 3.98 (q, 2H), 2.85 (dd, 2H), 1.07 (d, 3H), 0.97 (s, 9H), 
0.91 (s, 9H), 0.20 (s, 6H), 0.14 (s, 6H). ES+ TOF: (607.4 calc, C28H53ClNO5SSi2). 
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